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CHAPTER I 
 
INTRODUCTION 
 
Although the “central dogma of molecular biology” proposed that genetic 
information flows from DNA through RNA to the encoded protein (Crick, 1970; 
Crick, 1958); one can not always predict the exact RNA or amino acid sequence 
from the nucleotide sequence in the genomic DNA. The first example is RNA 
splicing in adenovirus (Berget et al., 1977; Chow et al., 1977), where segments 
of viral RNA from different regions of the viral genome are joined together to form 
the mature transcripts, suggesting the possibility of generating multiple gene 
products from the same genomic locus via RNA processing. Since then, 
numerous mechanistically distinct modifications have been identified in the 
process of eukaryotic RNA maturation, including capping, polyadenylation, 
alternative splicing, and most recently, RNA editing (Emeson et al., 1989; Kable 
et al., 1996; Keller and Minvielle-Sebastia, 1997; Varani, 1997; Wang and 
Manley, 1997).  
RNA editing was first discovered in a mitochondria transcripts encoding the 
cytochrome oxidase subunit II (coxII) in Trypanosoma brucei. In trypanosome 
coxII transcripts, four uridine residues are inserted into the RNA sequence to 
generate a open reading frame that can not be deduced from the genomic 
sequence (Benne et al., 1986). The existence of nucleotide insertion and deletion 
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within RNA sequences via different mechanisms has then been described in a 
variety of organisms, including amoebid protozoa, myxomycetes, chytriomycete 
fungi, nematodes, and RNA viruses (Grosjean and Benne, 1998). Although 
initially coined to describe nucleotide insertion/deletion, the term “RNA editing” is 
now used to describe a number of mechanistically distinctive RNA modifications, 
including post-transcriptional insertion/deletion (Kable et al., 1996; Seiwert, 1996), 
co-transcriptional insertion (Visomirski-Robic and Gott, 1997), nucleotide 
exchange (Price and Gray, 1999) and base modification/substitution (Auxilien et 
al., 1996; Sommer et al., 1991).  
 
RNA editing by base modification 
While purine-to-pyrimidine and pyrimidine-to-purine alterations have been 
reported (Price and Gray, 1999), most of the base modification/substitutions RNA 
editing identified to date result from deamination (adenosine-to-inosine, A-to-I 
and cytidine-to-uridine, C-to-U) or trans-amination (uridine-to-cytidine, U-to-C) 
reactions (Backus and Smith, 1991; Burns et al., 1997; Sharma et al., 1994). In 
mammals, the majority of RNA editing events involve nucleotide deamination, 
with the best-characterized examples being C-to-U and A-to-I conversions, in 
which hydrolytic deamination of cytidine or adenosine lead to the production of 
uridine and inosine nucleosides, respectively (Figure 1). These base 
modifications have been observed in both messenger RNA precursor (pre-mRNA) 
and mature mRNA transcripts. When such conversions occur in coding regions, it 
can lead to alterations in the coding potential of the transcript, resulting in the 
2
Cytidine Uridine
Adenosine Inosine
Figure 1 RNA editing by hydrolytic deamination
C-to-U and A-to-I conversions occur as results of hydrolytic deamination 
at C4 and C6 positions of the pyrimidine and purine rings, respectively, 
while the hydroxyl group (-OH) in water (H2O) serves as the nucleophile
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synthesis of protein products with altered functions (Bhalla et al., 2004; Burns et 
al., 1997; Chester et al., 2000; Lomeli et al., 1994; Sommer et al., 1991); 
whereas, nucleotide deamination in the non-coding region may affect almost all 
aspects of cellular RNA function including structure, stability, translation 
efficiency and splicing patterns (Knight and Bass, 2002; Kumar and Carmichael, 
1997; Prasanth et al., 2005; Rueter et al., 1999; Scadden and Smith, 2001).  
C-to-U RNA editing  
The first RNA editing identified in mammals was the C-to-U deamination in 
mRNA transcripts encoding apoplipoprotein B (apoB) (Chen et al., 1987), a key 
component in mammalian cholesterol metabolism. The ApoB protein exists in 
two functionally distinct forms, ApoB-48 and ApoB-100. Due to a single C-to-U 
editing event in the intestine, a glutamate codon (CAA) is converted into a stop 
codon (UAA), rendering an ApoB transcript to encode a protein isoform (Apo-48) 
lacking the low density lipoprotein (LDL) receptor binding domain at its carboxy-
terminus, which facilitates the transport of dietary lipids in the intestine. In the 
liver, the full-length ApoB protein (ApoB-100) is secreted as a component of 
lipoproteins to bind the LDL receptor, delivering cholesterol to cells by receptor-
mediated endocytosis (Figure 2) (Wang et al., 2003; Yao and McLeod, 1994). 
The C-to-U conversion in ApoB transcripts is catalyzed by a complex of proteins 
including a zinc-dependent cytidine deaminase, ApoB editing catalytic subunit 1 
(Apobec-1), and an accessory protein, apobec-1 complementation factor (ACF), 
which binds to apoB transcripts at an 11nt mooring sequence immediately 
downstream of the editing site (Backus and Smith, 1991; Mehta et al., 1996). 
4
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Figure 2 Apolipoprotein B editing
A. A schematic diagram of human apoplipoprotein B biosynthesis 
pathway is presented with the genomic organization of human ApoB 
gene shown at the top. Exons and intron are presented as solid bars 
and lines, respectively. The position of the start (ATG) and stop (TAA) 
codons are indicated. A C-to-U conversion in a glutamine codon (CAA) 
creates an in-frame stop codon (UAA) in ApoB transcripts expressed in 
the intestine, therefore producing a truncated protein, ApoB 48. 
(Adapted from Benny Hung-Junn Chang 1998)
B. A schematic representation of the minimal editing complex required 
for C-to-U editing in ApoB transcripts, including apobec-1 dimer and 
ACF which binds to the mooring sequence (underlined) near the editing 
s i t e  ( * ) .  ( A d a p t e d  f r o m  D r .  H a r o l d  C .  s m i t h ,  
http://www2.envmed.rochester.edu/envmed/TOX/faculty/smith.html.)
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Yeast mRNA containing mooring sequence homologous motifs also can be 
edited by ectopically expressed Apobec-1 (Dance et al., 2001), suggesting that 
the mooring sequence is sufficient for Apobec-1 mediated RNA editing.  
A second example of C-to-U RNA editing in mammals generates a translational 
termination codon at position 3916 in the neurofibromatosis type 1 (NF1) mRNA 
by site-specific deamination of an arginine (CGA) to a stop (UGA) codon 
(Mukhopadhyay et al., 2002). A truncated protein lacking a critical domain for 
GTPase activation is predicted to be encoded, however, the existence of such a 
protein has not yet been proved. This C-to-U modification has been observed in 
peripheral nerve sheath tumors from patients and may share elements of the 
same machinery responsible for apoB RNA editing (Blanc and Davidson, 2003).  
In transgenic mice and rabbits, overexpression of Apobec-1 in the liver had 
resulted in liver dysplasia and hepatocellular carcinomas. Aberrant editing also 
was found in transcripts encoding a translation factor, NAT-1, which is not edited 
in normal tissues. These results suggest that C-to-U editing may be important for 
the maintenance of normal cell growth; uncontrolled C-to-U RNA editing may 
aberrantly modify RNA transcripts and lead to tumorigenesis (Yamanaka et al., 
1995; Yamanaka et al., 1997).  
A-to-I RNA editing 
The most widespread type of base-modification editing is the conversion of 
adenosine to inosine (A-to-I), in which the C6-amino group on the adenine ring is 
substituted by a ketone (Auxilien et al., 1996), changing the targeted adenosine 
residue into inosine (Figure 1). Since the base-pairing properties of inosine are 
6
similar to guanosine, the edited adenosine will be read as guanosine during 
splicing, reverse transcription and translation. Inosine was first detected at 
position 34 and 37 in yeast alanine tRNA (tRNAAla), where inosine 34 is essential 
for base-pairing with cytosine, uridine or adenosine at the wobble position of 
degenerate codons during translation (Holley et al., 1965). In addition to tRNA, A-
to-I RNA editing events have also been described in pre-mRNA, mature RNA 
(Brusa et al., 1995; Burns et al., 1997; Higuchi et al., 2000; Hoopengardner et al., 
2003; Rueter et al., 1999; Sommer et al., 1991), and RNA viruses (Polson et al., 
1996), including the transcripts encoding the glutamate gated ion channel 
subunits (GluRs), the 2C subtype serotonin receptor (5-HT2CR), the voltage-
gated potassium channel subunit (Kv1.1), and Hepatitis delta virus (HDV), to 
modulate the coding potential of the targeted transcripts (Table 1). A-to-I 
conversion also has been described in non-translated RNA species and non-
coding regions of RNA transcripts. Despite that an A-to-I conversion in the intron 
of RNA editing enzyme (ADAR2) alters the pattern of alternative splicing (Rueter 
et al., 1999), the functional consequences of most non-coding region RNA editing 
have not been examined. There have been speculations that such RNA 
modifications may affect various aspects of RNA function including splicing, 
trafficking, translation efficiency and transcript stability (Athanasiadis et al., 2004; 
Blow et al., 2004; Kim et al., 2004; Levanon et al., 2004; Morse et al., 2002). 
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Adenosine deaminases that act on RNA (ADARs) 
A-to-I conversions are catalyzed by a family of enzymes known as adenosine 
deaminase that act on RNA (ADAR) (Bass et al., 1997). ADARs were identified 
initially based upon their ability to “unwind” double-stranded RNAs (dsRNA) when 
injected into Xenopus  oocytes (Bass and Weintraub, 1988), resulting from the 
conversion of stable adenosine-uridine (A-U) to unstable inosine-uridine (I-U) 
base-pairs. Meanwhile, A-to-I modifications were discovered to produce 
functional alterations in measles viral packaging proteins that generate nonlytic, 
persistent virions (Cattaneo et al., 1988; Cattaneo et al., 1989) and in the 
transcripts encoding the second subunit of the α-amino-3-hydroxy-5methyl-
4isoxazolepropionate (AMPA) glutamate receptor subunit 2 (GluR2) to alter the 
electrophysiological properties of the heteromeric glutamate gated ion channels 
(Sommer et al., 1991). Biochemical purification and molecular cloning have 
allowed the identification and characterization of ADAR proteins from variety of 
organisms. So far, three ADAR genes (ADAR1, ADAR2 and ADAR3) have been 
identified in mammals,  (Chen et al., 2000; Kim et al., 1994; Melcher et al., 1996a; 
Melcher et al., 1996b), while  two (ADR1 and ADR2) were found in C. elegans 
(Tonkin et al., 2002). In Drosophila, zebrafish and pufferfish, a single ADAR gene 
has been identified, respectively (Palladino et al., 2000b; Slavov et al., 2000).  
ADAR functional domains 
ADARs from all organisms share a common modular domain organization, 
including a variable amino-(N-) terminal region followed by one or several 
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double-stranded RNA (dsRNA) binding domains (dsRBDs) and a highly 
conserved catalytic domain in the carboxy- (C-) terminus (Figure 3). 
The N-terminal region – In mammals, the N-terminal region of ADAR1 contains 
one or two Z-DNA binding motifs (Herbert et al., 1997), which bind specifically to 
the left-handed Z-DNA conformation with high affinity. As the formation of Z-DNA 
occurs during transcription, there has been speculations that the Z-DNA domains 
of ADAR1 recognize Z-DNA to facilitate ADAR1 targeting a nascent RNA so that 
editing may occur prior to splicing. For ADAR2, a nuclear localization signal (NLS) 
was identified in front of the first dsRBD domain of the protein (Melcher et al., 
1996b); whereas in ADAR3, an arginine-rich single-stranded RNA (ssRNA) 
binding domain at the N-terminus is responsible for ADAR3 binding to ssRNA 
(Chen et al., 2000; Melcher et al., 1996b). 
The dsRBD – While C-to-U editing in ApoB transcripts targets a specific 
cytidine moiety by recognizing cis-acting elements including an 11-nucleotide 
motif (mooring sequence) four nucleotides downstream from the editing site 
(Figure 2) (Anant and Davidson, 2001; Maas and Rich, 2000), no specific primary 
sequences in the RNA are required for site-selective A-to-I conversion. Instead, 
A-to-I editing requires the binding of the dsRBD to regions of duplex RNA where 
the targeted adenosine residues are found (Bass, 2002; Higuchi et al., 1993; 
Rueter et al., 1999) (Figure 4). dsRBDs were first discovered in staufen, a protein 
required to localize mRNA transcripts to specific cytoplasmic sites for proper 
anterior patterning in Drosophila oocytes (Ferrandon et al., 1994; St Johnston et 
al., 1992).  To date, dsRBDs have been identified in a group of proteins with 
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NES NLS
NLS
NLS
Vertebrates
Insects
Nematodes
ADAR1 P-150
ADAR2
dADAR
ADR-1
ADR-2
ADAR3
Z-DNA-Binding Domain Double-strand RNA Binding Domain
Deaminase Domain Single-strand RNA Domain
Figure 3 Functional domains of ADARs from different species.
Schematic diagrams of domain structures for ADAR proteins from 
vertebrates, insects and nematodes are presented to depict the 
organization and phylogenetic conservation of functional domains in 
the enzymes that catalyze the A-to-I conversion in double-strand RNA 
substrates. The positions for nuclear export signal (NES) and nuclear 
localization signal (NLS) for vertebrate ADARs are indicated. 
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Figure 4 ADAR substrates require extended regions of duplex RNA. 
The predicted secondary structures of pre-mRNA transcripts encoding 
non-NMDA receptor subunits (GluR-2, GluR-5, and GluR-6), the 5-HT  
2C
receptor and the K 1.1 voltage-gated potassium channel are presented 
v
in the regions of major editing modifications using RNA folding 
algorithms. The positions of edited adenosine residues are indicated 
with open circles; exon and intron sequences are represented with 
uppercase and lowercase lettering, respectively, and the number of 
nucleotides omitted from the figure is indicated in the loops.
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diverse functions. In addition to Staufen, double-stranded RNA-dependent 
protein kinase (PKR) represents another well-characterized dsRNA-binding 
protein. Upon activation by dsRNA, PKR protects the host from viral infection by 
phosphorylation of eukaryotic initiation factor 2α (eIF2α), an important factor in 
the translation initiation machinery, thereby inhibiting protein translation in 
infected cells (Thomis et al., 1992). A third dsRBD containing protein, 
Escherichia coli (E. coli) ribonuclease III (RNase III), is part of a large family of 
dsRNA endonucleases that involve in the processing of mRNA, ribosomal RNA 
(rRNA), small nucleolar RNA (snoRNA), small nuclear RNA (snRNA) and micro 
RNA (miRNA) (Lamontagne et al., 2001). A consensus sequence that defines a 
65- to 68-amino acid of the dsRBD was first derived by comparing Drosophila 
staufen and Xenopus  laevis RNA-binding protein A (Xlrbpa) (St Johnston et al., 
1992). Among all known dsRBDs, a 42% amino acid sequence homology is 
revealed while the conservative amino acid changes are taken into account (St 
Johnston et al., 1992). For members of ADAR family, all proteins demonstrated 
high amino acid sequence conservation to the dsRBDs consensus sequence 
(Stefl et. al., 2005, in press).  
Nuclear magnetic resonance (NMR) studies on single dsRBD demonstrated 
that the dsRBD folds into a compact α−β−β−β−α structure with the alpha helices 
positioned on one side of an anti-parallel three-stranded beta-sheet (Bycroft et al., 
1995; Kharrat et al., 1995). X-ray crystallography studies on the second dsRBD 
of Xlrbpa complexed with dsRNA  demonstrated that the protein spanned 16 
basepair (bp) of dsRNA, interacting with two successive minor grooves and 
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across the intervening major groove on one face of a primarily A-form RNA helix. 
Further x-ray crystallographic and NMR studies of dsRBDs in complex with 
dsRNA showed that most interactions are sequence-independent and occur with 
the minor groove and the phophodiester backbone (Bass, 2002). These 
observations supported the specificity of dsRBD for dsRNA over ssRNA or 
dsDNA, as well as the apparent lack of sequence specificity for dsRBD binding to 
dsRNA (Ryter and Schultz, 1998). Key residues making contacts with RNAs in 
the staufen and Xlrbpa dsRBDs also have been identified by mutational analyses 
and are generally conserved in the dsRBDs of ADAR1 and ADAR2. NMR 
solution structures of tandem dsRBDs from PKR showed that high affinity binding 
is achieved through cooperation between the interactions of multiple dsRBDs 
(Nanduri et al., 2000). A similar strategy may be used by ADARs, which have 
multiple dsRBDs and bind to dsRNA with nanomolar affinity (Ohman et al., 
2000).
It is well accepted that the dsRBDs are important to the in A-to-I editing, but the 
exact roles of each dsRBD in the ADAR proteins are not clear. While the deletion 
of the first or the third dsRBDs from ADAR1 inhibited editing activity in vitro, 
suggesting that dsRBD is essential for targeting the ADAR substrates, the 
second dsRBD seemed to be dispensable. These results suggeste that the three 
dsRBDs are not functionally equivalent in the catalytic action of ADAR1 (Lai et al., 
1995). Replacing the dsRBDs of ADAR1 with those of PKR decreased the editing 
efficiency of natural ADAR1 sites, while non-specific editing within a synthetic, 
perfect RNA duplex was not significantly altered. In addition, ADAR1 splice 
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variants that differ in length of the spacer region between dsRBDs or the dsRBD 
and the deaminase domain have different editing efficiencies on the A-site of the 
5-HT2C receptor transcripts (Liu et al., 1999). These results suggest that the 
arrangement of the dsRBDs might be a key determinant of site specificity (Liu et 
al., 2000).  
Deaminase domain – Phylogenetic analyses have suggested that the ADAR 
family of enzymes evolved from a common ancestral mononucleotide cytidine 
deaminase (CDA) (Carter, 1995). The molecular mechanism for CDA 
deamination involves nucleophilic attack of the aminated carbon of pyrimidine (C-
4) rings (Carter, 1995). Crystallographic studies of E. coli CDA have shown that a 
glutamate residue participates in acid-base catalysis, facilitating protonation of 
the N-3 nitrogen, while a histidine and two cysteines comprise a signature 
metalloprotein zinc-coordination domain (Ireton et al., 2002). The equivalent 
glutamate residue in ADARs is conserved among multiple species, including 
human, mouse, rat, fly and worms, and is required for editing activity (Lai et al., 
1995). Substitution of this critical glutamate residue results the loss of ADAR 
catalytic activity, suggesting that ADARs catalyze adenosine deamination in 
dsRNA by a mechanism similar to that of CDA (Lai et al., 1995).  
In a recent study, the crystal structure of the catalytic domain of human ADAR2 
at 1.7 angstrom resolution has been reported (Macbeth et al., 2005). Detailed 
analysis revealed an ordered zinc ion surrounded by histidine 394 (H394), 
cystine 451 and 516 (C451 and C516), and glutamate 396 (E396) of human 
ADAR2 deaminase domain, which coordinates a water molecule that presumably 
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displaces ammonia during the deamination reaction. Unexpectedly, an inositol 
hexakisphosphate (IP6) molecule was found buried within the enzyme core. IP6 
has been implicated in many cellular functions, including RNA export, DNA repair, 
endocytosis, and chromatin remodeling (Hanakahi and West, 2002; Shen et al., 
2003; York et al., 1999). Although there are no reports that ADARs require a 
cofactor, ADAR2 expressed in a yeast strain that is deficient in IP6 synthesis 
demonstrates no catalytic activity, suggesting that IP6 is required for ADAR2 
activity (Macbeth et al., 2005). 
C-terminus – While the C-6 position of the adenosine ring is hidden in the 
narrow major groove of the dsRNA, the dsRBDs appear to interact solely with the 
minor and sugar-phosphate backbone (Polson et al., 1991). There has been 
speculation that ADARs overcome this inaccessibility through a base-flipping 
mechanism mediated by the extreme C-terminus of ADARs which has sequence 
homology to N-6-adenine methyltransferases (Hough and Bass, 1997).  However, 
direct evidence for the existence of such a functional domain and the exact role 
of the C-terminus in A-to-I conversion has not been identified.  
ADAR editing Specificity 
In contrast to the mechanism of Apobec-1-mediated C-to-U deamination, 
ADAR proteins target sites of deamination through recognition of highly ordered 
secondary structure (Auxilien et al., 1996; Higuchi et al., 1993) (Figure 4), and to 
date, no evidence suggests that any accessory factor is required to mediate 
ADAR-RNA interaction (Chen et al., 2000; Dawson et al., 2004). These enzymes 
can either deaminate up to 50% of the adenosine residues in an extended, 
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perfect dsRNA, or precisely target one specific adenosine moiety among many 
adenosines in a natural substrate (Polson et al., 1996). Although ADARs 
recognize their targets with no specific sequence requirements, several lines of 
evidences have shown that ADAR1 and ADAR2 have their own preferred 
neighboring sequence for targeting. Previous studies have shown that both 
ADAR1 and ADAR2 prefer a uridine as 5’ neighbor to the targeted adenosine. 
Although ADAR1 rarely target adenosine close to either terminus of synthetic 
dsRNA substrates, ADAR2 can deaminate adenosines as close as 3 nucleotides 
from either terminus, and it has a 3’ neighbor preference as uridine (U) (Lehmann 
and Bass, 2000; Polson and Bass, 1994; Polson et al., 1991). In a recent study, 
Dawson et. al. compared the surrounding sequences of several adenosines by 
ADAR2 , and suggested a "consensus" sequence surrounding ADAR2-modified 
residues may exist as an important contributor to ADAR2 preference and editing 
efficiency (Dawson et al., 2004).  
The detailed structures of RNAs may also influence the editing specificity. 
Adenosines in long, perfectly base-paired RNA duplex can be deaminated 
nonselectively (Nishikura et al., 1991; Polson and Bass, 1994); while shorter 
double-stranded RNA or RNAs with mismatches, bulges, or loops, undergo more 
selective deamination. It has been suggested that the disruptions within the 
duplex contribute to the selectivity of the reaction by limiting the access of ADAR 
binding to the short, perfect-matched RNA duplex regions (Lehmann and Bass, 
1999). 
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 ADARs in multiple species 
Mammalian ADAR  
Three ADAR genes have been identified in mammals. ADAR1 and ADAR2 are 
ubiquitously expressed, whereas ADAR3 is exclusively expressed in the brain 
(Chen et al., 2000). The highest expression of ADAR2 is in the brain (Melcher et 
al., 1996b), consistent with the observation that the brain has the highest level of 
inosine-containing mRNA compared with other tissues (Paul and Bass, 1998). 
While ADAR1 has three dsRBDs, ADAR2 and ADAR3 have two dsRBDs (Chen 
et al., 2000; Melcher et al., 1996a; Melcher et al., 1996b; Patterson et al., 1995). 
All three ADARs contain nuclear localization signals (NLS) and are localized to 
the nucleus, with the exception of the inducible isoform of ADAR1, which also 
carries an nuclear export signal (NES) in the N-terminal region of the protein and 
shuttles between the nuclear and cytoplasmic compartment of the cells 
(Strehblow et al., 2002). All mammalian ADAR proteins carry a conserved 
adenosine deamination domain, but only ADAR1 and ADAR2 demonstrate 
editing activity on extended duplex regions in synthetic RNA as well as naturally 
occurring pre-mRNA and viral RNA transcripts; ADAR3 is catalytically inactive on 
either extended RNA duplex or known editing substrates, despite the fact that it 
can bind both single- and double-strand RNA (Chen et al., 2000; George and 
Samuel, 1999; Kawakubo and Samuel, 2000; Melcher et al., 1996a; Melcher et 
al., 1996b). It has been suggested that ADAR3 might serve as a regulatory 
competitor of ADAR1 and ADAR2 within RNA substrates, thereby acting as an 
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inhibitor of A-to-I conversion (Chen et al., 2000), yet no evidence has been 
reported to support this hypothesis in vivo.  
Drosophila ADAR  
Drosophila expresses a single ADAR gene, dADAR, which encodes a protein 
with a deaminase domain and two dsRBDs. There is 42% amino acid homology 
between dADAR and human ADAR2 (Palladino et al., 2000a). Multiple dADAR 
mRNA isoform are generated by alternative transcription initiation and splicing 
(Figure 5 A). The transcripts driven by the 4a promoter are expressed during all 
developmental stages and undergo alternative splicing in the 5’-untranslated 
region and the region encoding the linker between the two dsRBDs; whereas, the 
expression from the 4b promoter is specific to adult flies (Palladino et al., 2000a). 
Interestingly, the dADAR transcript undergoes developmentally-regulated A-to-I 
modification, which changes a highly conserved serine (S) codon into a glycine 
(G) codon in the catalytic domain (Keegan et al., 2005) (Figure 5). The S/G site is 
close to motif II of the deaminase domain that is thought to chelate a zinc ion at 
the active site. Editing at the S/G site of dADAR was low in embryonic and pupal 
mRNAs and increased more than 40-fold from embryo to adult (Palladino et al., 
2000a). DADAR isoforms with the serine to glycine substitution are less active in 
vitro and in vivo compared with the genome-encoded, unedited isoform. Mutant 
flies ubiquitously expressing an dADAR cDNA engineered to resist RNA editing 
demonstrated embryonic lethality, suggesting the physiological significance of 
S/G site editing in the embryonic development of Drosophila (Keegan et al., 
2005). 
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dsRBD1 dsRBD2
A
B
S/G site
Figure 5 Alternative splicing and RNA editing of Drosophila ADAR.
A. The genomic organization of dADAR gene is presented with the 
constitutive exons ( ) and alternatively spliced exons ( ) indicated. 
Exons encoding 5' UTR are labeled with negative numbers and arrows 
represent the alternative transcription initiation sites. RNA editing 
occurs within exon 7 ( ). The regions encoding the two dsRBDs are 
indicated on top of the gene. (Adapted from Palladino et. al. 2000) 
B. The predicted RNA structure for exon 7 of dADAR transcript. The 
edited adenosine is indicated with an arrow. (Adapted Keegan et. al. 
2005) 
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C. elegans ADAR  
The C. elegans genome encodes two ADAR genes, ADR-1 and ADR-2. ADR-1 
encodes an enzyme with two dsRBDs and an atypical deaminase domain lacking 
the zinc-coordination and proton-shuttling residues (Tonkin et al., 2002). Five 
splice variants of ADR-1 have been identified. Expression of ADR-1 begins early 
in embryogenesis and continues to be expressed in all larval stages with the 
highest expression in the neuronal tissues. ADR-2, which encodes a protein 
containing a single dsRBD and a highly conserved catalytic deaminase domain, 
is the second gene in an operon of six genes and is expressed from early 
embryogenesis in most cells in the nervous system. ADR-2 mRNA are 
heterogeneous at their 5’ termini since multiple spliced leader variants are used 
during processing from the polycistronic transcripts (Tonkin et al., 2002). Both 
ADR-1 and -2 are required for the A-to-I editing in C. elegans (Tonkin et al., 
2002). Genetic studies indicate that while ADR-2 can function alone, the activity 
of ADR-1 is depend on the presence of ADR-2 (Tonkin et al., 2002). 
 
ADAR substrate identification and characterization 
Numerous RNAs have been found undergo A-to-I modifications, including 
those that alter the coding potential of the transcripts, such as RNA editing in 
transcripts encoding multiple subunits of ionotropic glutamate receptors (GluR2-
6), 5-HT2C receptors and Kv1.1 potassium channels. While most of the well-
characterized ADAR targets were discovered serendipitously, recent studies 
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using systematic screening strategies have predicted thousands of new editing 
sites, most of which are located in the non-coding regions of RNA transcripts.  
Substrate identification 
Originally, a limited number of A-to-I editing events were identified based on 
adenosine-to-guanosine (A-to-G) discrepancies during comparison of genomic 
and cDNA sequences (Burns et al., 1997; Rueter et al., 1999; Smith et al., 1996; 
Sommer et al., 1991). However, the limited number of endogenous ADAR 
substrates identified could not explain the significant amount of inosine in the 
brain mRNAs (Paul and Bass, 1998), nor do they provide adequate explanations 
for the adverse phenotype of mice with aberrant ADAR activity (Higuchi et al., 
2000; Wang et al., 2000). Therefore, several experimental approaches have 
been employed using either biochemical strategies or bioinformatics paradigms 
for systematic identification of novel A-to-I editing events.  
Biochemical approach  
Morse et.al. developed a series of biochemical strategies to specifically identify 
new A-to-I RNA editing substrates (Morse and Bass, 1997). The authors took the 
advantage of ribonuclease T1, which selectively cleave the 3’ of inosine residues 
within glyoxal-treated RNAs. The digested fragments were then amplified by RT-
PCR followed by sequence analysis. This approach allowed the successful 
identifications of ten and nineteen A-to-I editing events in RNA isolated from C. 
elegans and human brain, respectively (Morse et al., 2002; Morse and Bass, 
1999). All the novel editing substrates are predicted to form long hairpin 
structures in the targeted region, and further analysis revealed that a majority of 
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these edited regions were contained within repetitive elements, such as IR-2, -3, 
-4 and -5 elements in C. elegans and Alu and LINE elements in human.  
Comparative genomics approach  
A second approach to identify ADAR substrates is developed based on the fact 
that the sequences surrounding the editing site as well as the sequences 
complimentary to the editing site region are conserved among species (Rueter et 
al., 1999; Slavov and Gardiner, 2002). Using the high degree of sequence 
identity as a potential signature of ADAR substrates, Hoopengardner et.al 
compared genes annotated as ion channels (n = 135), G protein–coupled 
receptors (GPCRs, n = 178), proteins involved in synaptic transmission (n = 102), 
and transcription factors (n = 499), between Drosophila melanogaster and 
Drosophila pseudoobscura. They identified numerous new ADAR targets and 
successfully verified sixteen previously unknown ADAR target genes in the fruit 
fly (Table 1). All of these genes are involved in rapid electrical and chemical 
neurotransmission and many of the edited sites alter the codons for conserved 
and functionally important amino acids, indicating a pivotal role for RNA editing in 
regulating nervous system function in Drosophila (Hoopengardner et al., 2003). 
Further investigations on one of the novel Drosophila targets, Shaker, revealed 
that the human homologue of this potassium channel undergoes A-to-I 
conversion in a conserved isoleucine (I) codon. Substitution of the isoleucine 
residue with a valine residue by A-to-I conversion alters the channel kinetic in 
recovery from inactivation (Bhalla et al., 2004). 
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Computational approach  
With the recent knowledge of complete human genome sequences and the 
advanced technology in computational science, several groups have attempted 
to identify ADAR targets by comparison between cDNA and genomic sequence 
throughout the genome with the help of computational algorithm. Results from 
these studies revealed over 12,000 novel sites in more than 1600 genes in the 
human transcriptsome. 26 genes were experimentally validated, raising the 
number of known editing sites by two orders of magnitude (Blow et al., 2004; Kim 
et al., 2004; Levanon et al., 2004), Strikingly, most of these newly-identified A-to-I 
editing events occur in inverted repetitive elements, such as Alu (92%) and L1 
(1.3%) sequences, within the untranslated region. Search of database from other 
species using similar approach revealed that the frequency of A-to-I editing in 
humans is at least an order of magnitude higher than in the mouse, rat, chicken 
or fly transcriptsomes (Eisenberg et al., 2005). The extraordinary abundance of 
RNA editing in human can be explained by the dominance of Alu elements in the 
human transcriptsome, which dramatically increases the number of double-
stranded RNA. In the latest computational search in human transcriptsome, 
researchers identified and experimentally verified four codon-altering editing 
events in transcripts encoding the α subunit of filamin A (FLNA), bladder cancer 
associated protein (BLCAP), cytoplasmic FMR1 interacting protein 2 (CYFIP2) 
and insulin-like growth factor binding protein 7 (IGFBP7) (Table 1). Three of the 
four editing sites were verified in mouse while two were validated in chicken. 
None of these substrates encodes a receptor protein but two of them are strongly 
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expressed in the CNS suggesting that some of the affected proteins might be 
related to the altered physiological phenotypes of ADAR mutant mice (Levanon 
et al., 2005). 
Massive sequencing approach  
Taking the advantage of high-throughput DNA sequencing technique, Blow et. 
al. have conducted a survey of RNA editing in human brain using sequence 
analysis on clones from a human brain cDNA library and comparing those to the 
reference human genome sequence and to genomic DNA from the same 
individual (Blow et al., 2004). In their study, approximately 12,000 nucleotides 
were edited out of >3 mega base-pair (Mb) surveyed. All editing events identified 
were A-to-I conversions and were predominantly in intronic and intergenic RNAs, 
especially in high-copy-number repeats, such as Alu elements. While examining 
the sequences surrounding the editing site, they found the A-to-I conversion is 
less likely to happen at an adenosine 3' to a guanosine and more likely at an 
adenosine 5' to a guanosine. Simulation by BLAST alignment of the double-
stranded RNA molecules that underlie known editing sites indicates that there is 
a greater likelihood of A-->I editing at A:C mismatches than editing at other 
mismatches or at A: U matches. However, because A:U matches in double-
stranded RNA are more common than all other mismatches, overall the likely 
effect of editing is to increase the number of mismatches in double-stranded RNA 
(Blow et al., 2004). 
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Functional consequences of A-to-I conversions 
Once the targeted sites are modified by ADARs in the nucleus, the resultant 
transcripts are transported into the cytoplasm where they can be translated. 
Several well characterized A-to-I conversions involve non-synonymous codon 
changes in mRNA sequences, resulting in the production of protein products with 
altered functional properties. The most prominent examples are editing in 
transcripts encoding the GluR-2 to 6 subunits, the 5-HT2C receptor, and the Kv1.1 
channel subunits (Bhalla et al., 2004; Brusa et al., 1995; Burns et al., 1997; 
Hoopengardner et al., 2003; Niswender et al., 1999; Sommer et al., 1991). In 
addition, recent studies on A-to-I RNA editing events in the non-coding region 
demonstrated that these modifications are involved in modulation of splicing 
pattern and nuclear retention of the targeted transcripts (Kumar and Carmichael, 
1997; Prasanth et al., 2005; Rueter et al., 1999).  
RNA editing on GluR transcripts 
Glutamate is the major excitatory neurotransmitter in the vertebrate CNS and 
plays an important role in fast excitatory neurotransmission, synaptic plasticity, 
and is involved in both chronic and acute neural disorders including stroke, 
epilepsy, amyotrophic lateral sclerosis and Parkinson’s disease (Wisden and 
Seeburg, 1993). The ionotropic glutamate receptors (iGluRs) mediate fast 
neurotransmission at excitatory synapses in CNS and comprise 16 related 
subunits that can assemble into 3 oligomeric cation channels in postsynaptic 
membrane, including NMDA (N-methyl-D-asparate), AMPA and kainate 
receptors. They share the same tetrameric structure, in which four subunits 
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contribute to the inner channel lining a pore loop structure (Seeburg and Hartner, 
2003). A-to-I conversions can functionally modify 5 of these 16 subunits (subunit 
2-6) that are involved in AMPA and kainite receptor assembly, while no RNA 
editing events have been identified in transcripts encoding NMDA receptor 
subunits. 
A-to-I RNA editing in AMPA receptor transcripts constituted the first and best 
characterized example of A-to-I editing in mammals. The glutamine residue (Q) 
positioned at the hairpin loop in GluR2 is important in forming the narrow 
constriction of the channel and in determining the ion permeability of the channel. 
The modification of the CAG (glutamine, Q) codon into a CGG (arginine, R) 
codon by A-to-I editing (Q/R site editing) renders the channel impermeable to 
calcium ions and affects channel assembly in the endoplasmic reticulum (Figure 
6) (Greger et al., 2003; Sommer et al., 1991). The Q/R site is edited at almost 
100% in GluR2 transcripts isolated from the whole brain, with the exception of 
subsets of striatal and cortical neurons where underedited (Q/R site) GluR-2 
subunits are expressed. This decreased level of editing provides an potential 
explanation for the high vulnerability to excitotoxicity of these neurons (Kim et al., 
2001). Decreased GluR-2 Q/R site editing was also observed in human brain 
tumors, and a link was proposed between lowered GluR-2 editing (Q/R site) and 
the occurrence of epileptic seizures associated with malignant gliomas (Kim et al., 
2001). Genetically modified mice expressing only one non-edited (Q/R site) 
GluR-2 allele die of seizures at three weeks of age, demonstrating the 
importance of editing at this particular site for normal brain function (Brusa et al., 
29
BA
HOOC
NH
2
I/V
Y/C
Q/R
R/G
extracellular
intracellular
K K
Glu
Na
NaCa
Glu
Q R
Figure 6 RNA editing of ionotropic glutamate receptor subunits.
A. A schematic diagram of the proposed topology structure of non-NMDA 
ionotropic glutamate receptor subunits is presented with the editing site 
indicated. The amino acids encoded by the nonedited/edited codon are 
represented in circles. The Q/R site is contained in RNAs encoding GluR-2, -5 
and -6 subunits, the R/G site is in transcripts encoding GluR-2, -3 and -4, while 
the I/V and Y/C site are only found in GluR-6 transcripts.
B. A cartoon diagram of the ion permeation properties of heteromeric AMPA 
receptor containing GluR-2 subunits encoded by the nonedited (Q) and edited 
(R) transcripts, respectively. The cations through the channel are indicated as 
balls with labels and the arrows indicate the direction of the cation flow.
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1995). Both in vitro and in vivo studies have indicated that ADAR2 is responsible 
for Q/R site editing in GluR-2 transcripts (Higuchi et al., 2000; Melcher et al., 
1996b). Similar to the editing-deficient GluR-2 mutant mice, the ADAR2 null mice 
is prone to seizures and died shortly after birth (Higuchi et al., 2000). Interestingly, 
the adverse phenotype demonstrated in mice lacking the expression of ADAR2 
can be rescued by introducing a point mutant at the Q/R site of GluR-2 gene to 
generate sole arginine-containing subunits, suggesting the seizure and lethal 
phenotype in the ADAR2 deficient mice is primarily due to lack of editing at the 
GluR-2 Q/R site (Higuchi et al., 2000). It is still puzzling why GluR-2 Q/R site 
occurs as a result of A-to-I editing rather than encoding the critical arginine 
residue within genomic DNA, as genetically modified mice expressing GluR-2 
with a genomically encoded arginine at the Q/R site demonstrated no discernable 
phenotype (Kask et al., 1998).  
In addition to Q/R site editing, ADAR binding to a separate duplex structure in 
the GluR-2 transcripts (Figure 4) converts an arginine (R) into a glycine (G) 
codon. The conversion is important in regulating channel kinetics, since the 
glycine-containing AMPA receptor recovers more rapidly from receptor 
inactivation compared with the arginine containing isoform (Lomeli et al., 1994).  
Similar A-to-I modifications are also observed in the subunits of heteromeric 
kainate receptors, which are less abundant in the brain than the NMDA and 
AMPA receptors. At the position homologous to the GluR-2 Q/R site, the GluR-5 
and GluR-6 kainate receptor subunits are expressed in both their edited (R) and 
nonedited (Q) forms. In contrast to the GluR-2 Q/R site editing, the efficiencies of 
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GluR-5 and -6 Q/R site editing are low at embryonic stage and rise during 
postnatal developmental maturation, suggesting that the channels may play 
different roles during development. The physiological and functional relevance of 
Q/R site editing in GluR-6 RNA has been revealed by genetically modified mice, 
in which Q/R site editing in GluR-6 transcripts is abrogated by deletion of an 
intron sequence that is crucial for editing (Vissel et al., 2001). The mutant mice 
exhibited NMDA receptor-independent long-term potentiation (LTP) at the medial 
perforant path-dentate gyrus synapse and both heterozygous and homozygous 
mutant mice were more vulnerable to kainate-induced seizures (Vissel et al., 
2001). These findings indicate a clear role for GluR-6 Q/R site editing in synaptic 
plasticity and circuit excitability. Increased Q/R site editing of GluR-5 and GluR-6 
subunits was observed in brain tissue excised from patients with temporal lobe 
epilepsy, and was suggested to result from an adaptive reaction to ongoing 
seizure activity (Kortenbruck et al., 2001); however, the mechanism underlining 
this proposed regulation of A-to-I editing for kainate receptors is unknown.  
RNA editing on 5-HT2C receptor transcripts 
Serotonin (5-hydroxytryptamine; 5-HT) is a monoamine neurotransmitter that 
modulates numerous sensory and motor processes as well as a wide variety of 
behavior including locomotion, thermoregulation, pain perception, sleep, appetite, 
and sexual behavior (Sanders-Bush et al., 2003). Serotonin activates at least 14 
distinct receptor subtypes that differ in their tissue localization, binding affinity for 
5-HT and coupling to intracellular signaling pathways (Hoyer et al., 1994). The 5-
HT2 family includes three members, 2A, 2B and 2C receptors. The typical 
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signaling pathway for this family of serotonin receptor is Gq-coupled activation of 
phospholipase C (PLC), therefore increasing intracellular concentrations of 
inositol phosphates (IP) and diacylglycerol (DAG). In addition, both 
phospholipase D (PLD) and phospholipase A2 (PLA2) can also be activated by 
5-HT2A and 5-HT2C receptors of 5-HT2 family, by interacting with additional G 
proteins (Sanders-Bush et al., 2003).  
To date, 5-HT2C receptor is the only known GPCR of whom the transcript 
undergoes RNA editing modification. In this post-transcriptional process, five 
genomically encoded adenosines can be converted into inosines in pre-mRNA, 
changing up to three amino acids codons in the second intracellular loop of the 
receptor, to generate 23 more protein isoforms for 5-HT2C receptor (Figure 7). 
The functional consequences of RNA editing in the 5-HT2CR transcripts was 
revealed in heterologous tissue culture system where different 5-HT2C receptor 
isoforms were expressed and assayed for their ability to activate PLC in 
response to 5-HT. These results demonstrated that the fully edited isoforms 
(VGV) exhibit the lowest potency for agonist stimulation of PLC activation and 
have reduced constitutive activity compared to the non-edited (INI) isoform due 
to less efficiency in G-protein coupling (Niswender et.al., 1999; Price et. al., 2001; 
Wang et. al., 2000b) Different brain regions express unique complement of 
nonediting/edited 5-HT2C receptor transcripts (table 2), while the non-edited INI 
isoform is dominant in chorus plexus in both human and rodents, the most 
prevailing isoform in the cortex, hypothalamus, hippocampus, olfactory bulb and 
striatum are VSV (human) and VNV (rat, mouse), suggesting that editing may 
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Figure 7 RNA editing of 5-HT2C R transcripts.
A. A schematic diagram of the predicted topology structure of 5-HT  receptor and 
2C
signaling pathway involved in activation of PLC. The approximate positions of 
amino acid alterations within the second intracellular loop of the receptor, resulting 
from RNA editing, are indicated. 
B. The nucleotide sequence alignment between 5-HT R genomic, mRNA and 
2C
cDNA sequences; the nucleotide discrepancies (inverse letters) and the predicted 
amino acid alterations (bold letter) and five editing sites are indicated.
C. 5-HT potency to activate phosphoinositide hydrolysis in NIH3T3 fibroblasts 
transiently transfected with different human 5-HT  receptor editing isoforms, (*, 
2C
p<0.05; **, p<0.01).  (Adapted from Niswender et. al. 2001) 
34
heterotrimeric
G-protein
PLCPI
GTP
bgGaq
NH
2
HOOC
DAGIP3
PKC
2+
Ca
Y V A I N P I E H S RR
Y V A V
M
G
S
D
P V E H S RR
genomic DNA
cDNA
mRNA
TAT GTA GCA T  CGT T CCT TT GAG CAT AGC CGTG G GG G
TAT GTA GCA T  CGT T CCT TT GAG CAT AGC CGTI I II I
TAT GTA GCA T  CGT T CCT TT GAG CAT AGC CGTA A AA A
A B C DEediting site:
human 5-HT R isoform
2C
20
40
60
80
5
-H
T
 E
C
 (
n
M
)
5
0
INI VSIINV VNV ISV VSV VGV
*
**
A
B
C
35
Table 2 5-HT2C receptor editing isoform distribution in different
brain regions of adult mice
RNA from whole mouse brain (WB), choroid plexus (CP), cortex (C),
hippocampus (Hi), hypothalamus (Hy), olfactory bulb (OB) and
striatum (Str) of 129Sv/Ev/Tac adult male mice were amplified by RT-
PCR, subcloned into pGEM-T vector and individual cDNA isolates
(>50 from each brain region) were analyzed by Pyrosequencing™
analysis. The percentage of cDNA isolates encoding each amino
acid isoform for each brain region is presented.
36
represent a fine-tuning mechanism to modulate 5-HT2C receptor function in 
various areas in CNS.    
RNA editing of Kv1.1 transcripts  
Voltage-gated potassium channels (Kv) are integral membrane proteins that 
enable the passage of potassium ions across cell membranes. These channels 
open and close in response to changes in transmembrane voltage and play a 
critical role in limiting neuronal excitability (Sands et al., 2005). Mice lacking the 
Shaker-like voltage-gated potassium channel Kv1.1 alpha-subunit developed 
recurrent spontaneous seizures early in postnatal development (Rho et al., 1999). 
Mutations in the KCNA1 locus (the human homologue of Kv1.1) also have been 
identified in patients affected by episodic ataxia and myokymia (Lerche et al., 
2001). The voltage-gated potassium channels are comprised of four subunits that 
encircle a central ion conduction pathway. Each subunit consists of six alpha 
helices (S1- S6) (Figure 8). The first four transmembrane helices (S1-S4) form 
the voltage sensing domain, whereas the last two transmembrane helices (S5-S6) 
along with an intervening reentrant P loop, form the pore domain (Yellen, 2002). 
The very rapid signaling in neurons requires a fast mechanism for closing and 
opening the pore. The inactivation mechanism for Kv1 channel involves the N- 
terminus of an associated beta-subunit blocking the channel (Rettig et al., 1994). 
 Using comparative genomic analysis, Hoopengardner et. al. first identified 
multiple editing sites in three Drosophila potassium channel genes, shaker, 
ether-a-go-go and slowpoke. While applying the same screening strategy to 
mammalian shaker genes, orthologs of the Kv1.1 gene in mouse, rat and human 
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Figure 8 RNA editing of K 1.1 transcripts
v
A. A schematic representation of the three states of K 1.1 subunits 
v
(gray) associated with the b subunit (black). A K+ current (I ) can be 
K
elicited in response to membrane depolarization (V ) and then 
m
decreased by the inactivating particle (black oval) interacting with the 
isoleucine in the pore (open ovals). Substitution of the isoleucine to a 
valine moiety, as a result of A-to-I editing modification, is predicted to 
w e a k e n t h i s i n t e r a c t i o n . ( A d a p t e d f r o m B e z a n i l l a , 2 0 0 4 ) 
B.The predicted topology structure of K 1.1 subunit within the 
v
membrane with membrane-spanning domains (S1−S6) and the 
position of the edited I/V site (*) represented on the top. The amino 
acid sequence alignment of the S6 domains of K  channels from 
V
multiple species are demonstrated at the bottom with the RNA editing 
targeted isoleucine shaded. (Adapted from Hoopengardner et. a., 
2003) 
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demonstrated a region of high sequence conservation and a single A-to-I 
conversion was found within this conserved region (Hoopengardner et al., 2003). 
This RNA modification occurs at an isoleucine (I) codon, conserved through fly to 
human, in the S6 fragment of the Kv1.1 protein. Once the isoleucine codon is 
converted into valine (V) codon by RNA editing, the transcripts encode channels 
with a 20 time faster rate of recovery from inactivation (Bhalla et al., 2004; 
Hoopengardner et al., 2003), suggesting a potential regulatory role of RNA 
editing in potassium channel kinetics.  
RNA editing in UTRs 
Although systematic screenings for novel ADAR substrates in human 
transcriptsome increased the number of editing substrates by at least an order of 
magnitude, only a few editing sites were identified in the coding region (Blow et 
al., 2004; Kim et al., 2004; Levanon et al., 2004); the majority of the A-to-I 
conversions are predicted in non-translated RNA species and UTRs of RNA 
transcripts, especially inverted Alu repeats. Alu elements are short interspersed 
elements (SINEs), comprising >10% of the human genome. They are typically 
repeats can form extended RNA duplexes, the only known requirement for 
ADAR-mediated deamination, it is not surprising to find that the RNA sequences 
containing Alu repeats undergo extensive A-to-I modifications. It is not clear 
which ADAR is responsible to the Alu editing (Eisenberg et al., 2005). 
Using the same strategy to identify new ADAR substrates in mouse, chicken 
and flies, Eisenberg et. al. found  that the frequencies of A-to-I editing in these 
species are at least an order of magnitude lower than in the human, even though 
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the total numbers of SINEs in human and rodent genomes are similar (Eisenberg 
et al., 2005). This discrepancy can be explained by the fact that while rodent 
genome contains various SINEs, only one SINE, Alu element, dominates human 
genome, so it is more probable to form dsRNA from two consecutive and 
oppositely orientated SINEs in the human transcriptsome.  
It has been speculated that UTR editing may affect RNA splicing, trafficking, 
translation efficiency and transcript stability. Previous studies from polyoma virus 
showed that early-strand transcripts isolated late in infection underwent intensive 
A-to-I RNA editing and accumulated within the nucleus of the infected cells, 
suggesting that extensive A-to-I modifications may induce nuclear retention of 
target transcripts (Kumar and Carmichael, 1997). Recently, an 8 kb, non-protein 
producing transcript transcribed from the mouse cationic amino acid transporter2 
gene (CAT2), CTN-RNA has been identified to localize in paraspeckles and to be 
in complex with p54nrb, an inosine-containing RNA binding protein. The 3’UTR of 
CTN-RNA contains sequence elements that can form an imperfect RNA for 
ADAR mediated adenosine deamination and undergoes intensive A-to-I 
conversions. A-to-I editing in the 3’UTR of CTN-RNA and its interaction with 
p54nrb suggest that A-to-I conversion in the untranslated regions may serve as a 
mechanism to regulate RNA translocation, therefore affecting the translational 
efficiency or stability of the target transcripts.  
A-to-I editing in other species  
A remarkable number of transcripts in invertebrates are also targeted by 
ADARs. The majority of known invertebrate editing sites occur in the coding 
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region of transcripts encoding neurotransmitter receptors, channels and proteins 
involved in rapid electrical and chemical neurotransmission. To date, RNA editing 
in invertebrates includes A-to-I conversions in transcripts encoding nicotinic 
acetylcholine receptors (Grauso et al., 2002), GABA receptors (Hoopengardner 
et al., 2003), calcium channel subunits (Palladino et al., 2000b; Smith et al., 
1998), sodium channels (Hanrahan et al., 1999; Hanrahan et al., 2000; Song et 
al., 2004), delayed rectifying potassium channels (Bhalla et al., 2004; Patton et 
al., 1997; Rosenthal and Bezanilla, 2002), glutamate-gated chloride channels 
(Semenov and Pak, 1999) and proteins involved in synaptic release 
(Hoopengardner et al., 2003) (Table 1).  
Preliminary analysis of the RNA editing in squid potassium channel, SqKv1.1, 
revealed that editing-mediated amino acid alterations affect both channel gating 
properties and subunit tetramerization (Rosenthal and Bezanilla, 2002); in 
addition, two editing events in SqKv2 modulated the rates of channel closure and 
slowed inactivation (Patton et al., 1997). A single editing event in the German 
cockroach Na channel transcript, BgNav1-2, has also been found to be critical to 
the voltage dependence of channel activation (Song et al., 2004). However, in 
most cases, the functional consequences of these editing events have not yet 
been elucidated. Further investigations of the biological roles of the gene 
products encoded by these transcripts and the consequences of editing will help 
to provide more insight into the physiological significance of A-to-I RNA editing in 
the invertebrate species. 
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Physiological significance of ADAR activity 
dADAR mutant Drosophila  
dADAR-null flies have been generated using transposon-mediated P-element 
excision (Palladino et al., 2000b). Under ideal growth conditions, the dADAR 
deficient flies developed into morphologically normal adults, with only a structural 
defect in the retinas of young animals. However, adult mutants demonstrated 
uncoordination and paralysis with severe motion defects in jumping, fighting, 
tremors and mating (Palladino et al., 2000b). In addition, vacuolated lesions 
appeared in the brain by day 30 in mutant flies. Most of the behavioral defect and 
the lesions in the brain of the dADAR null files became more severe during aging 
(Chen et al., 2004). The phenotypes associated with loss of dADAR activity are 
consistent with perturbations of electrical and chemical signaling mechanisms in 
the nervous system and proximal effects on behavior (Palladino et al., 2000b). 
Mutations generated in some of the ion channel which are targets of dADAR 
developed similar behavioral phenotypes to the dADAR deficient flies, suggesting 
that it is those targets responsible for the defect observed in dADAR mutant flies. 
With most of the newly identified A-to-I conversions occurring in the coding 
regions of genes involved in rapid neurotransmission (Hoopengardner et al., 
2003), it is suggested that a primary role of dADAR is to modulate 
neurotransmission in the CNS. Recently, it was found that dADAR deficient flies 
had prolonged recovery from anoxia stupor and altered gene expression for 
reactive oxygen species (ROS) scavengers, suggesting that dADAR may also be 
involved in regulating the expression of genes encoding ROS scavengers (Chen 
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et al., 2004; Ma et al., 2001). The ability of dADAR to edit its own mRNA has 
been identified at a serine codon in the conserved region of the deaminase 
domain; dADAR isoforms with the serine to glycine substitution close to the 
ADAR active site are less active in vitro and in vivo than the genomically 
encoded, nonedited isoform (Keegan et al., 2005). Ubiquitous expression of an 
non-edited dADAR transcript in embryos and larvae is lethal, suggesting dADAR 
autoediting is essential for normal development in Drosophila (Keegan et al., 
2005).    
ADR mutant C. elegans  
While C. elegans lacking ADR-1 had severely reduced A-to-I editing activity, 
ablation of ADR-2 expression eliminated the editing activity entirely, suggesting 
that ADR-2 can function by its own but ADR-1 may require ADR-2 for activity and 
perhaps the two enzymes act together as a heterodimer (Tonkin et al., 2002). 
Although C. elegans strains containing homozygous deletions in either or both 
ADAR genes are viable, they both demonstrated chemotaxis defects (Tonkin et 
al., 2002). More intriguing, the ADR mutant worms can be rescued by loss-
function mutations in genes involved in RNA interference (RNAi) pathways, 
suggesting that the phenotype of ADR deletion strains may be caused by 
aberrant RNAi activity and ADARs may play a role in regulating the RNAi 
pathway (Tonkin and Bass, 2003).  
ADAR mutant mice 
In contrast to ADARs in worms and flies, ADAR1 and ADAR2 expressions are 
absolutely essential in mammals. ADAR1 and ADAR2 knockout mice generated 
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by gene-targeted homologous recombination both die during development. As 
early as embryonic day 11.5 (E11.5), mouse embryos lacking ADAR1 expression 
demonstrated rapid disintegration of the liver structure, severe defects in 
embryonic erythropoiesis and stress-induced apoptosis (Hartner et al., 2004; 
Wang et al., 2000; Wang et al., 2004), suggesting that ADAR1 serves critical 
steps in embryonic development, especially in developing non-nervous tissue. 
Intercrosses between heterozygote ADAR2 null mice produced homozygote mice 
at the expected Mendelian frequency, indicating that ADAR2 deficiency does not 
result in embryonic development (Higuchi et al., 2000). However, homozygote 
ADAR2 null mice developed progressive seizure after birth and died between 
postnatal day 0 (P0) and 21 (P21) (Higuchi et al., 2000). Remarkably, the 
phenotype of ADAR2 null animals can be rescued by replacing both wild-type 
GluR-2 alleles with an arginine-containing alleles at the Q/R site, despite the fact 
that editing of many other sites, including the R/G site of GluR-2, the Q/R site of 
GluR-5 and the D site of 5-HT2CR, were all significantly reduced in ADAR2 null 
animals (Higuchi et al., 2000).  These results demonstrated that the lethality in 
ADAR2 null mice primarily results from the loss of Q/R site editing in GluR-2 
transcripts.  
Recent studies from our laboratory demonstrated that transgenic mice 
expressing rat ADAR2 protein under the control of Cytomegalovirus (CMV) 
promoter developed adult-onset obesity characterized by hyperglycemia, 
hyperleptinemia and increased adiposity. This phenotype predominantly resulted 
from hyperphagia rather than a metabolic derangement, because during a 
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paired-feeding analysis, mutant mice on caloric restriction had similar growth rate 
and body composition to wild-type littermates. Although the molecular 
mechanism underlining the obesity phenotype has not been identified, the editing 
activity of ADAR2 is not required for the hyperphagia since an enzymatically 
inactive rat ADAR2 transgene expression gave rise to similar outcome. 
Expression of inactive rADAR2 also had decreased editing at ADAR1 substrates 
suggesting a molecular mechanism by which the double-stranded RNA binding 
activity of ADAR2 could interfere with the actions of other double-stranded RNA 
binding proteins therefore producing phenotypic alterations in the animals (Dr. 
Minati Singh, unpublished data). 
 
Regulation of ADAR activity 
Unlike the static changes imparted by genetic polymorphisms, RNA editing 
modifications are subject to spatial and temporal regulation in response to 
cellular cues (Gurevich et al., 2002a; Yang et al., 2004), offering an organism 
great potential for complex patterns of gene expression. When functioning 
improperly, this essential process can give rise to pathological conditions ranging 
from epilepsy to embryonic lethality. Therefore, it is critical for the organisms to 
precisely regulate ADAR activity.  
ADAR Dimerization 
As previously identified for CDA, ADARs have been shown to form dimers on 
dsRNA (Cho et al., 2003; Gallo et al., 2003). Cho et. al. investigated the 
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formation of complexes between differentially epitope-tagged ADAR monomers 
by sequential affinity chromatography and size exclusion column 
chromatography, and demonstrated that while both ADAR1 and ADAR2 form a 
stable enzymatically active homodimer complex, ADAR3 remains as a 
monomeric, enzymatically inactive form. No heterodimer complex formation 
among different ADAR gene family members was detected. Interestingly, 
endogenous ADAR3 in brain extracts was found to form a homodimer complex, 
indicating the presence of a brain-specific mechanism for ADAR3 dimerization 
(Cho et al., 2003). In addition, dADARs form homodimers on dsRNA, and the 
minimum region required for dimerization is the N-terminus and the first dsRBD 
(dsRBD1). Single point mutations within dsRBD1 abolish RNA-binding activity 
and dimer formation. In addition, mutant dADAR protein with deletion of the N-
terminus, although retains the ability to bind dsRNA, is monomeric and inactive, 
indicating that dimerization is essential for editing but not dsRNA-binding activity 
(Gallo et al., 2003).  
Transcriptional regulation 
Although in situ hybridization studies showed that ADAR2 mRNA expression is 
developmentally regulated (Paupard et al., 2000), studies on the transcriptional 
regulation of ADAR2 gene have not been reported. However, two alternative 
exon 1 structures in human ADAR1 gene have been identified using 5’ rapid 
amplification of cDNA ends (RACE) assay (Figure 9). While the exon 1B-exon 2 
transcripts encoding an N-terminally truncated 110-kD protein are synthesized 
constitutively, exon1A-exon2 transcripts encoding a 150-kD protein are interferon 
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(IFN) inducible (George and Samuel, 1999). The constitutive P110 ADAR1 
protein has one Z-DNA binding domain, three dsRBDs and a deaminase domain, 
whereas the inducible P150 ADAR1 protein has an extra Z-DNA binding domain 
and a nuclear export signal (NES) at the N-terminal of the protein (George and 
Samuel, 1999). To date, similar alternative transcription initiation has also been 
identified in mouse ADAR1 gene (George et al., 2005). Using transient 
transfection analysis with reporter constructs, two functional promoters was 
characterized as Pc, for constitutional expression of exon1B-exon2 transcripts, 
and Pi, for inducible expression of exon 1A-exon2 transcripts (George and 
Samuel, 1999). The IFN responsive Pi promoter of the ADAR1 gene possesses 
an IFN-stimulated response element (ISRE) responsible for IFN-inducibility, as 
well as an adjacent upstream sequence, designated kinase conserved sequence 
(KCS), which has been identified as an important IFN responsive element in the 
PKR gene promoter (Markle et al., 2003).  
The IFN inducibility of ADAR1 expression is thought to represent a defensive 
mechanism protecting cells from viral infection. One ADAR1 target is the 
antigenome of Hepatitis delta virus (HDV), an RNA intermediate formed during 
the replication of HDV RNA genome (Polson et al., 1996). ADAR1-mediated RNA 
editing at the amber/W site of HDV antigenomic RNA results in the conversion of 
an in-frame stop codon into a tryptophan (W) codon, leading to the production of 
a longer form (HDAg-L), which is required for viral packaging and can also serve 
as a potent trans-dominant inhibitor of HDV RNA replication. Increased 
expression of ADAR1 strongly correlates with the inhibition of HDV RNA 
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replication, suggesting overexpression of ADAR1 may compromise the virus 
viability (Jayan and Casey, 2002). The increased expression of p150 ADAR1 
also has been found in response to acute inflammation, microbial infections, and 
IFN treatment, resulting in an elevation of the overall inosine content in the 
inflammatory organs as well as increased editing at specific ADAR1 sties (Jayan 
and Casey, 2002; Yang et al., 2003a; Yang et al., 2003b; Yang et al., 2004). 
However, the exact role of ADAR1 during these inflammatory processes is under 
further investigation. 
Subnuclear localization 
Since most known RNA duplex structures targeted by ADAR include both exon 
and intron sequences, it is reasoned that ADARs must function before RNA 
splicing and translocation from the nucleus to the cytoplasm. Despite the 
postulated role of ADARs in the nucleoplasm near sites of transcription, several 
groups have demonstrated that ADAR1 and ADAR2 accumulate in the nucleolus, 
a subnuclear structure where ribosomal RNA (rRNA) synthesis, processing and 
ribosomal subunit assembly take place (Desterro et al., 2003; Sansam et al., 
2003)  There are multiple nucleoli in a cell, and each nucleolus is formed around 
many actively transcribed rDNAs within chromosomal loci called nucleolar 
organizing regions (NORs). Using a GFP-ADAR2 fusion protein, Sansam et. al. 
demonstrated that ADAR2 shuttles between the nucleoplasm and the nucleolus 
in the living cells (Sansam et al., 2003). When cells express the GluR-2 RNA 
duplex, endogenous ADAR1 and ADAR2 de-localized from the nucleolus and 
accumulated in the nucleoplasm where the substrate transcripts accumulate 
49
(Desterro et al., 2003), suggesting a binding competition between the GluR2 
duplex in the nucleoplasm and the extensive intermolecular base-pairing formed 
in rRNA. When NIH3T3 cells were treated with ribonuclease A (RNase A), a 
rapid loss of nucleolar localization of the GFP-ADAR2 was seen; and inhibition of 
rRNA synthesis caused translocation of ADAR2 from nucleolus to the 
nucleoplasm, suggesting that the ADAR2 nucleolar localization is RNA 
dependent. To test whether the nucleolar localization of ADAR2 affects editing 
activity, rRNA synthesis in rat C6 glioma cells and mouse NIH3T3 fibroblasts was 
inhibited to force the translocation of ADAR2 from nucleoli to the nucleoplasm. 
As measured by the extent of editing at endogenous ADAR2 substrates, a 
significant increase in ADAR2 activity was observed, indicating that the nucleolus 
serves as a storage depot for ADAR2, not a site of action, and alteration of 
ADAR subnuclear localization represents a mechanism for prompt regulation of 
ADAR activity in response to the abundance of ADAR substrates in the 
nucleoplasm. 
Sumoylation 
Sumoylation is a highly dynamic posttranslational modification that involves the 
covalent attachment of the small ubiqutin-like modifier, SUMO, to target proteins 
in eukaryotes. It can affect the target protein functions by altering its subcellular 
localization, activity or stability. The modification process involves formation of an 
isopeptide bond between the C-terminus of SUMO and the ε-amino group of a 
lysine residue of the target protein; while the removal of SUMO from proteins is 
carried out by specific cysteine proteases that have both hydrolase and 
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isopeptidase activity. In vertebrates, three SUMO proteins are identified as 
SUMO-1, -2 and -3; and sumoylation has been found in proteins such as 
RanGAP1, PCNA, IkBa, p53, c-jun, topoisomerases, promyelocytic leukemia 
protein, Sp100 and the mitogen-activated protein kinase kinase 1, most of which 
are nuclear proteins or proteins shuttling to the nucleus (Hay, 2005). In addition, 
since most enzymes involved in SUMO pathway are also localized in the nucleus, 
it is believed that sumoylation is predominantly a nuclear process (Seeler and 
Dejean, 2003; Zhang et al., 2002).  
In recent studies (Pinto Desterro et al., 2005), subnucleolar localization of 
SUMO-1 was found to overlap with ADAR1 in a region that is distinct from fibrillar 
center, the dense fibrillar component and the granular component, raising the 
possibility that ADAR1 is a target for SUMO-1. Further analysis demonstrated 
that ADAR1 can be modified by SUMO-1 at lysine residue 418. Substitution of 
this lysine residue with an arginine abolished sumoylation but did not affect the 
nucleolar localization of ADAR1. Moreover, modification of ADAR1 by SUMO-1 
reduced RNA editing activity. Although ADAR1 and ADAR2 co-localize in the 
nucleolus, ADAR2 does not have any SUMO-1 consensus motif, therefore it is 
not surprising that ADAR2 is not modified by SUMO-1 in vitro (Pinto Desterro, 
unpublished data). In summary, results from Pinto Desterro et. al. demonstrated 
a novel posttranslational modification mechanism to regulate ADAR1 activity.  
Alternative Splicing  
Alternative splicing is an important mechanism for generating multiple protein 
isoforms possessing different biological activities from a single genomic locus. 
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Both ADAR1 and ADAR2 genes undergo alternative splicing to diversify the 
function of the encoded products. For ADAR1, three naturally occurring splice 
variant isoforms were identified for the IFN inducible mRNA isoform. While the 
full-length 1226-amino acid ADAR1 protein was designated ADAR1-a, the variant 
designated ADAR1-b contains a deletion of 26 amino acids between the third 
dsRBD and the catalytic deaminase domain due to 5'-splice site selection at the 
exon 7-intron 7 junction. The ADAR1-c variant has an additional deletion of 19 
amino acids at the intron 5-exon 6 junction which lies between the second and 
third dsRBDs (Liu et al., 1997). All three alternative splice variants are expressed 
in human kidney, while only the ADAR-a and -b forms were detected in a human 
placenta library (Liu et al., 1997). Since these alternative splicing events retain 
the dsRBDs functionally intact, all three of the ADAR1 mRNA isoforms encode 
active enzymes that possess comparable deaminase activity measured with a 
synthetic dsRNA substrate. However, site-directed mutagenesis of the dsRBDs 
revealed that the presence of one or both of the deletions in the spacer regions 
between the dsRBDs and the catalytic domain of the ADAR-b and -c variants 
altered the functional importance of each of the individual dsRNA binding motif 
relative to that observed for ADAR-a. The 26-amino acid deletion of exon 7 
between the third dsRBD and the deaminase domain in ADAR-b, as well as the 
additional 19-amino acid deletion between the last two dsRBDs in ADAR-c, 
appeared to gradually reduce the functional significance of the first dsRBD (Liu et 
al., 1997).  
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Similar to ADAR1, multiple splice variants of ADAR2 mRNA have been 
identified in ADAR2 mRNA in rats, mice and humans (Gerber et al., 1997; Rueter 
et al., 1999; Slavov and Gardiner, 2002). A subset of these RNA processing 
events are conserved in all three species (Figure 10). One such splicing event in 
the region of the transcripts encoding the deaminase domain results in the 
production of ADAR2 protein isoforms containing an additional 40 (human) or 10 
(rat, mouse) amino acids between the second and third zinc coordination 
residues of the deaminase domain, to generate enzymes that are approximately 
twice as active as those lacking the insertion (Gerber et al., 1997; Rueter et al., 
1999).  
A second alternative splicing event near the 5’-end of the coding region in 
ADAR2 transcripts was identified to insert a 47-nucleotide cassette immediately 
upstream of exon 5, generating a -1 frame-shift that is predicted to produce a 
9kD protein lacking the dsRBDs and the deaminase domain required for protein 
function, due to premature translation termination (Rueter et al., 1999; Slavov 
and Gardiner, 2002). This alternative splicing event is dependent upon the ability 
of ADAR2 to edit its own pre-mRNA (ADAR2 autoediting), converting an 
adenosine residue within intron 4 to inosine (-1 site), thereby creating a non-
canonical AI dinucleotide that serves as a novel 3’- splice acceptor (Rueter et al., 
1999). As with all identified ADAR substrates, editing at the -1 site of ADAR2 
requires an imperfect RNA duplex formed by the base-pairing of sequences 
surrounding the -1 site with an inverted repeat referred to as the editing site 
complimentary sequence (ECS). In the rat, the ECS is located approximately 
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Figure 10 The conserved alternative splicing events in ADAR2 
gene.
The genomic structure of mouse ADAR2 gene is presented with the 
sizes of the exons indicated at the top. The alternative splicing events 
between exon 3 and 5, and exon 8 and 9, leading to the introduction 
of 47 or 30 nucleotides (  ) in the open reading frame (boxed letters), 
respectively, are demonstrated at the bottom. The RNA editing site 
that creates a proximal splice acceptor site upstream of exon 5 is 
indicated.
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1.4kb upstream of the -1 site in intron 4 (Rueter et al., 1999), and this region of 
the intron demonstrates a high level of sequence conservation with 
corresponding sequences from ADAR2 genes isolated from all characterized 
vertebrate species including pufferfish, zebrafish, chicken, mouse and human 
(Figure 11) (Rueter et al., 1999; Slavov and Gardiner, 2002). Deletion of the ECS 
region resulted in the ablation of editing at the -1 site in heterologous expression 
systems, while deletion of intronic sequences between the ECS and the region 
surrounding the -1 site had little effect on the extent of A-to-I conversion (Dawson 
et al., 2004; Rueter et al., 1999).  
 
Specific aims 
Since the ADAR2 autoediting and subsequent alternative splicing result in the 
generation of a premature translation termination in ADAR mRNA and are 
conserved among all vertebrate species, ranging from zebrafish, to human 
(Slavov and Gardiner, 2002), we hypothesized that ADAR2 autoediting 
represents a negative feedback mechanism to modulate the level of ADAR2 
protein expression and activity. As ADAR2 protein expression increases, the 
enzyme can promote the splicing machinery to generate 47 nucleotides 
containing mRNA isoforms by producing more A-I dinucleotide at the proximal 
splice acceptor, therefore decrease the level of mRNA isoforms that encode full-
length functional protein, to counteract the increase of ADAR2 protein (Figure 12). 
To test whether this molecular processing is essential for the ADAR2 expression 
and activity in vivo, genetically modified mice have been developed in which 
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ADAR2 autoediting was selectively ablated (ΔECS mice), giving rise to the 
following specific aims. 
 
Specific Aim 1: to examine the consequence of ECS deletion on ADAR2 
RNA processing. 
 
Previous studies have demonstrated that the ECS element is essential for the -
1 site editing in ADAR2 minigene constructs transfected in the heterologous 
tissue culture systems (Dawson et al., 2004; Rueter et al., 1999). In the current 
study, RNA from ΔECS mice will be assessed for the extent of editing at the -1 
site as compared with wild-type littermates.  
Since -1 site editing is a prerequisite for the 47 nucleotide inclusion in the 
ADAR2 mRNA, it is reasoned that ablation of ADAR2 autoediting will abrogate 
the generation of ADAR2 mRNA isoforms containing the 47 nucleotide cassette. 
The 47 nucleotide insertion will be characterized in RNA isolated from multiple 
tissues of ΔECS and wild-type mice. 
 
Specific Aim 2: to examine the effect of ablation of ADAR2 autoediting on 
ADAR2 function. 
 
Once the ADAR2 autoediting and consequent alternative splicing are ablated, 
we hypothesized that the proposed negative feedback loop by which ADAR2 
control its own protein expression will be disrupted in the homozygous ΔECS 
mice, and therefore ADAR2 protein expression as well as ADAR2 enzymatic 
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activity will be altered. Total proteins from ΔECS mice will be quantified for 
ADAR2 expression and compared with the expression in wild-type counterparts. 
For analysis of ADAR2 activity, extent of editing at ADAR2 substrates will be 
quantified. 
 
Specific Aim 3: to characterized the phenotypic alteration in mice lacking 
ADAR2 autoediting. 
 
ADAR2 autoediting is conserved in all vertebrate species; it is an essential 
regulation for the normal function of the animals. In addition, many ADAR2 
substrates are transcripts encoding proteins with critical CNS functions. It is then 
reasoned that deregulation of ADAR2 activity will result in abnormality in animal 
physiology and behavior. Wild-type and ΔECS homozygous mice will be 
subjected to physiological and neurological examinations to provide deeper 
insight on the physiological significance of ADAR2 activity.  
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CHAPTER II 
 
REGULATION OF ADAR2 EXPRESSION BY AUTOEDIITNG 
 
Introduction 
The conversion of adenosine to inosine by RNA editing is a widespread 
posttranscriptional modification resulting in the hydrolytic deamination of 
selective adenosine residues to alter the sequence of RNA transcripts from that 
encoded by genomic DNA. The majority of well characterized A-to-I editing 
events involve non-synonymous codon changes in mRNA sequences, resulting 
in the production of proteins with altered functional properties. In mammals, the 
most prominent examples of A-to-I editing have been described for transcripts 
encoding ionotropic glutamate receptor subunits (GluR), a voltage-gated 
potassium channel subunit (Kv 1.1) and the 2C-subtype of the serotonin receptor 
(5-HT2CR), which lead to the production of channels with altered 
electrophysiological and ion permeation properties (Bhalla et al., 2004; 
Hoopengardner et al., 2003; Kohler et al., 1993; Krampfl et al., 2002; Lomeli et 
al., 1994; Seeburg and Hartner, 2003) and receptors with decreased G-protein 
coupling efficiency (Berg et al., 2001; Burns et al., 1997; Niswender et al., 1999). 
A-to-I modifications have also been described in non-translated RNA species and 
non-coding regions of RNA transcripts, suggesting that such RNA modifications 
may also affect other aspects of RNA function including splicing, trafficking, 
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translation efficiency and transcript stability (Athanasiadis et al., 2004; Blow et al., 
2004; Kim et al., 2004; Levanon et al., 2004; Morse et al., 2002).  
A-to-I RNA editing in mammals is mediated by a family of enzymes known as 
ADARs, including ADAR1, ADAR2 and ADAR3 (Bass et al., 1997). While ADAR3 
is exclusively expressed in the brain with no detectable deaminase activity (Chen 
et al., 2000), ADAR1 and ADAR2 are ubiquitously expressed and mediate A-to-I 
conversions in synthetic dsRNAs as well as naturally occurring substrates  
(Higuchi et al., 2000; Lehmann and Bass, 2000; Melcher et al., 1996a; Melcher et 
al., 1996b; Wang et al., 2000). ADAR2, a 80 kD nuclear protein with two dsRBDs 
in the N-terminal and a deaminase domain in the C-terminal is responsible for the 
majority of the known codon-altering A-to-I modifications (Hartner et al., 2004; 
Higuchi et al., 2000; Wang et al., 2004). Genetically modified mice lacking 
ADAR2 expression develop progressive seizures and die by day 21 due to lack 
of editing (Q/R site) in transcripts encoding GluR-2 subunit (Higuchi et al., 2000), 
demonstrating the critical role that ADAR2 plays in the normal development and 
function of the CNS.  
Multiple splice variants of ADAR2 have been identified in rats, mice and 
humans, yet only a subset of these RNA processing events are conserved in all 
three species (Gerber et al., 1997; Rueter et al., 1999; Slavov and Gardiner, 
2002). One such splicing event results in the production of ADAR2 protein 
isoforms containing an additional 40 (human) or 10 (rat, mouse) amino acids 
between the second and third zinc coordination residues of the deaminase 
domain, generating enzymes that are approximately twice as active as those 
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lacking the insertion (Gerber et al., 1997; Rueter et al., 1999). Alternative 3’-
splice site selection near the 5’-end of the coding region introduces additional 47 
nucleotides, creating a -1 frame-shift that is predicted to produce a 9KD protein 
lacking the dsRBD and the deaminase domain required for protein function 
(Rueter et al., 1999; Slavov and Gardiner, 2002). Previous studies have 
demonstrated that this alternative splicing event is dependent upon the ability of 
ADAR2 to edit its own pre-mRNA, converting an adenosine residue within intron 
4 to inosine (-1 site), thereby creating a non-canonical AI dinucleotide that serves 
as a novel 3’- splice acceptor (Rueter et al., 1999). As with all identified ADAR 
substrates, editing at the -1 site of ADAR2 requires an imperfect RNA duplex 
formed by the base-pairing of sequences surrounding the -1 site with an inverted 
repeat referred to as the editing site complimentary sequence (ECS). In the rat, 
the ECS is located approximately 1.4kb upstream of the -1 site in intron 4 (Rueter 
et al., 1999), and this region of the intron demonstrates a high level of sequence 
conservation with corresponding sequences from ADAR2 genes isolated from all 
characterized vertebrate species including pufferfish, zebrafish, chicken, mouse 
and human (Figure 11) (Rueter et al., 1999; Slavov and Gardiner, 2002). In vitro 
analysis showed that deletion of the ECS region resulted in the ablation of editing 
at the -1 site, while deletion of intronic sequences between the ECS and the 
region surrounding the -1 site had little effect on the extent of A-to-I conversion 
(Dawson et al., 2004; Rueter et al., 1999), demonstrating that ECS is required for 
the editing  at the -1 site. 
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The ability of ADAR2 to edit and direct alternative splicing of its own pre-mRNA 
may represent an autoregulatory mechanism by which ADAR2 can prevent its 
own overexpression to avoid increased levels of editing for numerous ADAR2 
substrates. To determine whether autoediting can serve to prevent ADAR2 
overexpression, and to characterize the subsequent consequence of lacking 
ADAR2 autoediting, our laboratory generated genetically modified mice in which 
the ability of ADAR2 to edit its own transcript has been selectively ablated.  
 
Materials and Methods 
 
Generation of mutant mice 
Detailed description of the targeting vector construction is presented in the 
doctoral thesis of Dr. Chris Sansam. Briefly, the targeting vector was generated 
from two 129/SvEvTac mouse genomic bacterial artificial chromosome (BAC) 
clones (Genome Systems, Inc.) containing the ADAR2 gene. A short arm 
fragment, extending from the 3’-end of intron 2 to a region upstream of the ECS 
element in intron 4 (-4053 to -1575- base pairs relative to the -1 editing site), was 
floxed by PCR with primers containing the loxP sequence and inserted between 
XhoI and BamHI sites, replacing the first LoxP site within sites in the LoxP-Neo-
TK vector (a generous gift from Dr. Mark Magnuson, Vanderbilt University). A 
7.4kb long arm, harboring the remainder of intron 4 downstream of ECS element 
through intron 6 (-1369 to +6061 relative to the -1 editing site), was inserted 
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between SalI and NotI sites in the LoxP-Neo-TK vector. A 195bp ECS containing 
intronic fragment (-1517 to -1322 bp relative to the -1 site) was inserted between 
the two adjacent LoxP sites using BamHI digestion. The thymidine kinase gene 
was excised from the targeting vector by EcoRI digestion to eliminate the 
previously described toxicity of thymidine kinase to the male germline (Braun et 
al., 1990; Ellison et al., 1995).  
The ClaI-linearized targeting construct was electroporated into 129/SvEvTac 
derived embryonic stem (ES) cells. The integration of the targeting vector and the 
fidelity of homologous recombination were confirmed by Southern blotting 
analysis using 5’- and 3’- probes outside the region of homology and the correctly 
targeted ES cells were microinjected into C57BL/6 blastocysts. High percentage 
chimeras were mated with 129/SvEvTac animals to obtain heterozygous mice 
bearing the targeted allele (3lox; Fig 12A). The heterozygous 3lox mice in 
129/SvEvTac background were then mated with EIIA-Cre transgenic mice 
developed on a C57BL/6 background (a generous gift from Dr. Richard Breyer, 
Vanderbilt University) to delete the region between the loxP sites early in 
embryogenesis (Lakso et al., 1996; Xu et al., 2001). Progeny from this mating 
were analyzed by PCR and direct DNA sequence analysis for the loss of the 
entire region containing the selectable marker and a 209 bp region of ADAR2 
gene containing the ECS (ΔECS, Figure 13). Mutant mice bearing the ΔECS 
alleles were mated with wild-type C57Bl/6J animals and subsequent progeny 
were assessed for the presence of the modified ADAR2 allele and segregation of 
the Cre transgene. 
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 Genotype analysis 
The wild-type and targeted (3lox; Figure 13A) alleles were distinguished using 
a polymerase chain reaction (PCR)-based strategy with sense (VU 649, 5’-
TGTGAGCAGATGTAGCGTGTGAT-3’) and antisense (VU 695, 5’-AATTTTCAT 
TTATAACATCCTC-3’) primers, flanking the upstream loxP site to generate PCR 
amplicons of 140 and 174 bp for wild-type and targeted alleles, respectively. To 
distinguish between the wild-type and ΔECS alleles, PCR was performed using 
sense (VU 649, 5’-TGTGAGCAGATGTAGCGTGTGAT-3’) and antisense (VU 
650, 5’-GCGGGCAGGGTTAATGTGATGA-3’) primers flanking the ECS region to 
generate a 343 and a 172 bp amplicons for the wild-type and the ΔECS alleles, 
respectively. 
 
Tissue collection and RNA isolation 
All animals were provided ad lib access to food and maintained on a 12hr 
light/dark cycle. Male ΔECS mice and wild-type litter mates were sacrificed at the 
age of 4 weeks according to the procedures approved by the institute of animal 
care and us committee (IACUC) at Vanderbilt University. Organs were quickly 
removed, immediately frozen in liquid nitrogen, and later stored at -80oC. Total 
RNA was isolated from 50-100mg tissue using the Versagene RNA tissue kit 
(Gentra Bystems). All procedures were conducted according to the 
manufacturer’s instructions. Genomic DNA contamination was eliminated from all 
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RNA samples using Versagene DNase Kit (Gentra Biosystems) followed the 
manufacturer’s protocol. The quantity and qualify of the RNA samples were 
assessed using the Nano-drop ND-3300 Fluorospectrometer (NanoDrop 
Technologies). The 260/280 absorbance ratio of samples ranged from 1.90 to 
2.10, indicating good integrity and little DNA or protein contamination of the 
isolated RNA. 
 
Quantitative Fluorescent RT-PCR analysis of ADAR2 mRNA splice 
variants 
 
To quantify the relative expression of ADAR2 mRNA splice variants in RNAs 
isolated from tissues in wild-type and ΔECS mice, first-strand cDNA was 
synthesized from 1 ug of total RNA by AMV RT (Promega) in a 10ul reaction 
containing an antisense primer (VU 459, 5’-GCGGTTTTCTTTAACATCAGTGC-
3’), 1mM dNTPs (New England Biolabs) and 10U RNasin (Promega) at 42oC for 
1 hour followed by 95oC for 5min. The cDNA was then amplified with 6-
carboxyfluorescein (6-FAM) labeled sense primer (VU929, 5’-
CGCTTGCTATTTTAGTGCTGCGG-3’) and an antisense primer (VU 459, 5’-
GCGGTTTTCTTTAACATCAGTGC-3’), using Ampli Taq (Applied Biosystems) as 
follows: 94oC for 2min, followed by 35 cycles of 94 oC for 15 seconds, 60oC 30 
seconds and 72oC for 2 minutes, and 1 cycle at 72 oC 7min. 5ul of the PCR 
reactions was then resolved by 2.5% agarose gel electrophesis at 80 volts in 
darkness at room temperature for 2.5 hours, and fluorescence quantified using a 
Molecular Dynamics phosphorimager (Amersham Biosciences). 
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 Quantification of RNA Editing 
To quantify the site-selective editing of different ADAR substrates, first-strand 
cDNA was synthesized from 1ug of total RNA using 10U AMV RT in a 10ul 
reaction containing 5uM random hexamers (Applied Biosystems, Foster City, CA), 
1mM dNTP (New England Biolabs, Beverly, MA) and 10U Rnasin, under 
condition 25oC  for 10minuts, 42oC for 1hr and 95oC for 5 minutes, and then PCR 
amplified using Ampli Taq DNA polymerase (Applied Biosystems), and assessed 
by a modified primer-extension analysis (Rueter et al., 1999). The PCR primers, 
extension primer and mixtures of dideoxynucleotides used in each primer-
extension assay and the sizes of expected products are listed in Table 3. The 
extension products were resolved by denaturing poly acrylamide gel 
electrophesis, and quantified using a Molecular Dynamics phosphorimager 
(Amersham Biosciences). 
 
Real-time RT-PCR analysis 
To quantify the mRNA expression of ADAR1 and ADAR2 in RNAs isolated 
from tissues in wild-type and ΔECS mice, first-strand cDNA was synthesized from 
500 ng of total RNA using 10U AMV RT in a 10ul reaction containing 5uM 
random hexmers, 1mM dNTPs and 10U RNasin as follows: 25oC for 10 minutes, 
42oC for 1hr and 95oC for 5 minutes and subjected to Taqman real time PCR 
analysis (Applied Biosystems). All primers and probes used in the real-time PCR 
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Figure 13 Targeting strategy for the selective ablation of ADAR2 
autoediting.
A. A schematic diagram of a portion of the mouse ADAR2 gene is 
presented, extending from exon 3 through exon 6, before and after 
targeted gene modification. The positions of the positive selectable 
marker (PGK-neo), the editing-site complementary sequence (ECS) 
and the alternative 3'-splice site generated by ADAR2 autoediting (*) 
are indicated. The positions of primer pairs used for genotype analysis 
(  ), introduced loxP recombination sites for selective deletion of the 
PGK-neo cassette and the ECS region (  ), and DNA sequences outside 
the region of targeting vector homology (- - -) are shown. 
B. Analysis of mouse genotype by PCR amplification of mouse tail 
genomic DNA. The migrat ion pos i t ions for PCR ampl icons 
corresponding to the wild-type (+/+; 343 bp) and ECS (-/-; 172 bp) 
alleles are indicated.
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reactions were products of Assay-On-Demand from Applied Biosystmes (ADAR1, 
Assay ID Mm00508001_m1; ADAR2, Assay ID Mm00504621_m1). VIC/MGB 
labeled Eukaryotic 18S rRNA endogenous control (product# 4319413E, Applied 
Biosystems) was included in each multiplex PCR. The Real-time PCR reaction 
and subsequent analysis were performed with the ABI Prism 7900HT Sequence 
Detection System (SDS v2.1, Applied Biosystems). PCR amplification conditions 
were as follows: 1 cycle at 50oC, 2min; 1 cycle at 95oC, 10min; 40cycles of 15 
seconds at 95oC followed by 1 minunite at 60oC. Quantitation of target gene 
expression in all samples was normalized to 18S rRNA expression (Cttarget-
Ct18S=ΔCt). The mean ΔCt value of samples from each tissue for all wild-type 
animals was determined and used as a reference point for the samples from the 
same tissues in ΔECS mice. Differences between wild-type and ΔECS mice, 
including individual variation, were calculated by the equation (ΔCt individual ΔECS - 
ΔCt mean wild-type =ΔΔCt). Fold changes in target gene expression in each sample 
were calculated by 2-ΔΔCt, from which the mean and SEM were derived. 
 
Ribonuclease Protection Assay 
For quantification of ADAR2 mRNA isoforms, ribonuclease (RNase) protection 
analyses was performed, essentially as described (Emeson et al., 1989), using 
an antisense probe uniformly labeled with  [α-32P]-UTP corresponding to a region 
from -88 to +314bp, relative to the start codon of the mouse ADAR2 cDNA 
(Genbank accession no. AF403109). The probe generates a 408 nt protected 
fragment from RNA isoforms lacking of both the 47 nucleotide insertion and exon 
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4, and a 321 nt partially protected fragment from RNA isoforms containing 47 
nucleotide insertion or exon 4 or both and the unprocessed RNA precursor 
(Figure 17A). A 111 nt antisense RNA probe for cyclophilin was used as an 
internal control for RNA loading and normalization of expression levels. Reaction 
products were separated on a 4% poly acrylamide/7M urea gel and the relative 
levels of protected fragments were quantified using a Molecular Dynamics phos-
phorimager (Amersham Biosciences). 
 
Quantitative Western blotting analysis 
Tissue homogenates were prepared in RIPA buffer (150mM NaCl, 1% Igepal 
CA630, 0.5% Na deoxycholate, 0.1% SDS, 50mM Tris pH 7.6, 1mM PMSF, 
2ug/ml Leupeptin, 0.1% Aprotonin) using a polytron homogenizer. The 
homogenate was spun in a microcentrifuge at 13000 rpm for 15min at 4oC to 
remove particulate matter. The supernatant was then sonicated for 5 seconds on 
ice to shear genomic DNA followed by centrifugation at 13000 rpm at 4oC for 10 
minutes and then the supernatant was stored at -80oC. Expression levels of 
ADAR2 and β-actin in tissue homogenates from wild-type and ΔECS mice were 
analyzed by Western blotting analysis using an anti-ADAR2 polyclonal antibody 
(1:250 V/V) (Rueter et al., 1999; Sansam et al., 2003) and an anti-β-actin 
monoclonal antibody (1:500 V/V, sc-1616, Santa Cruz Biotechnology) 
respectively. An anti-goat secondary antibody labeled with Alexa Fluor 680 that 
excites at 650 nm and emits at 702 nm (1 to 10,000, V/V, A21084, Molecular 
Probes, Eugene, OR) was used to recognize both primary antibodies and the 
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fluorescent was directly detected using the Odyssey infrared imaging system in 
accordance with the manufacturer's instructions (Li-Cor Biosciences, Lincoln, NE). 
 
Mouse growth rate analysis 
To compare the growth rate between wild-type and ΔECS mice, age-matched 
male littermates were provided ad lib access to food and maintained within a 
facility of 12hr light/dark cycle. Body weight was monitored weekly at 3pm 
Thursday afternoon to minimize the variability from feeding schedule and the 
circadian rhythm.  
 
Neurological examination - IRWIN screen 
Age-matched male littermates were genotyped at age of week 3. 5 animals of 
the same genotypes (wild-type and homozygous ΔECS) were maintained ad lib 
in the same cage since week 3 within a facility of 12hr light/dark cycle. Age-
matched male heterozygous littermates were used to make the population in 
each cage equal to five. The animals were undisturbed till week 8, and then 
transferred to the room next to the screening facility and stayed for another week. 
During the week before screening, one cage with 4 homozygous ΔECS mice was 
flooded by water leaking, so the mice were sacrificed since stressed animal can 
not be used in the test. 7 wild-type and 7 homozygous ΔECS mice were screen 
in two consecutive morning followed by the IRWIN screen protocol provided by 
the Vanderbilt mouse neuro-behavior laboratory (Appendix I). 
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 Statistical analysis 
For most experiments, student’s t-test was performed using GraphPadPRISM 
(GraphPad Software, Inc.). Values are reported as mean"SEM. For growth rate 
analysis, two-way ANOVA was performed using GraphPadPRISM (GraphPad 
Software, Inc.). Values are reported as mean"SEM; P < 0.05 was considered 
statistically significant.  *, P<0.05; **, P<0.01; ***, P<0.001. 
 
Results 
 
Generation of ΔECS mice 
The ΔECS mice were developed initially by Dr. Chris Sansam, a former 
graduate student in the laboratory. Detailed descriptions of the strategy for 
assembling of the targeting vector to generate ΔECS animals are presented in 
the Ph.D. thesis of Dr. Sansam. A brief summary of this work has been included 
here to provide for better understanding of the studies presented in this 
dissertation. 
To selectively eliminate ADAR2 autoediting, the ECS region in mouse ADAR2 
gene was deleted to disrupt the conserved duplex structure, similar to previous 
studies in which editing of the Q/R site in GluR-2 pre-mRNAs was disrupted by 
deletion of intronic sequences containing the ECS (Brusa et al., 1995). Since 
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previous studies have demonstrated that ablation of ADAR2 expression results in 
early-onset seizures and postnatal lethality (Higuchi et al., 2000), the P1 
bacteriophage Cre-loxP system (Xu et al., 2001) was used to generate mutant 
mouse strains in which the ECS region could be conditionally deleted to 
circumvent the possibility of a lethal phenotype. Mutant mice that were 
heterozygous for the targeted ADAR2 allele (3-lox, Figure 13A) were mated to 
transgenic animals expressing Cre recombinase under the control of the EIIA 
promoter (Lakso et al., 1996) to delete the DNA sequences between the loxP 
sites early in embryogenesis. Progeny from this mating lost either the PGK-
neomycin cassette alone (lox-ECS-lox, Figure 13A) or the region of ADAR2 gene 
containing the ECS (lox-neo-lox) or both (ΔECS, Figure 13A). The heterozygous 
ΔECS mice were then mated with C57Bl/6 to segregate the Cre transgene from 
the mutant ADAR2 allele. Heterozygous ΔECS mice without the Cre transgene 
were then interbred and progeny demonstrated the expected Mendelian 
frequency (34 wild-type (+/+), 67 heterozygous (+/-), and 44 homozygous mutant 
(-/-); χ2=2.2, p>0.25), as assessed using a PCR-based assay (Figure 13B); no 
obvious phenotypic alterations were observed in animals homozygous for the 
ΔECS mutation. 
 
Ablation of ADAR2 pre-mRNA -1 site editing and alternative splicing in 
ΔECS mice 
 
To determine if the ECS element is essential for ADAR2 autoediting in vivo, we 
quantified the extent of editing at the -1 site in ADAR2 pre-mRNA transcript from 
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multiple tissues of wild-type and homozygous ΔECS mice. Reverse transcription-
polymerase chain reaction (RT-PCR) was performed to amplify the -1 site 
containing fragment from ADAR2 pre-mRNA. Since the PCR strategy amplifies 
both ADAR pre-mRNA and genomic DNA, an RT-PCR reaction with no reverse 
transcriptase was included for each sample to monitor possible genomic DNA 
contamination. The amplicons were then subjected to a modified primer-
extension assay (Rueter et al., 1999). The extent of editing at the -1 site in 
ADAR2 pre-mRNAs varied widely in tissues from wild-type animals (Figure 14), 
with the greatest levels of editing observed in lung (32%), followed by the brain 
(23%), the heart (17%), the  liver (16%) and the lowest in the testis (8%). By 
contrast, only background levels of editing were observed in tissues from the 
homozygous ΔECS mice. These data are consistent with previous in vitro studies 
and further confirmed the critical role of the ECS element for the A-to-I 
conversion at the -1 site.   
Since the generation of an A-I dinucleotide to form a functional 3’-splice site in 
intron 4 requires ADAR2 autoediting, abrogation of this RNA processing event 
should result in the sole use of the distal splice acceptor immediately preceding 
exon 5, leading to production of ADAR2 mRNAs encoding a full-length, functional 
protein. Recent studies have demonstrated that in addition to alternative 3’-splice 
site selection, an additional exon (exon 4) was identified 174 bp downstream of 
exon 3 (Slavov and Gardiner, 2002). Inclusion of this 73 bp exon was found to 
take place at a low frequency in ADAR2 transcripts isolated from mouse brain 
and is predicted to cause a frameshift resulting in premature translation 
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Figure 14 Ablation of ADAR2 autoediting ECS mice.  
The extent of editing at the -1 site in ADAR2 pre-mRNA isolated from 
different tissues of wild-type (  ) and ECS(  ) mice was determined by 
primer-extension analysis; values were obtained from tissue isolated 
from 3 animals per genotype (mean±SEM) 
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termination (Slavov and Gardiner, 2002). As a result of these alternative splicing 
events, four ADAR2 splice variants can be generated in the region between exon 
3 and 5 (Fig 15A). Among these four mRNA isoforms, only the isoform lacking 
both exon 4 and the 47-nucleotide cassette (3/5 -47) is able to encode a full-
length, functional ADAR2 protein. To quantify the relative abundance of ADAR2 
splice variants, we developed a quantitative RT-PCR-based strategy using a 6-
carboxyfluorescein (6-FAM) labeled sense PCR primer, which allowed us to 
directly quantify the PCR amplicon.  
The quantitative accuracy of this method was tested by amplifying a series of 
templates with mixtures of plasmids containing or lacking the 47 nucleotide 
cassette at fixed ratios. The amplicons from the plasmid PCR were quantified 
and the observed ratio of the +47 and -47 isoform was plotted against the 
expected ratio (Figure 15B). The linear regression analysis demonstrated that the 
data fits very well with the equation Y=X, where Y stands for the observed ratio, 
and X for the expected, demonstrating that this method can precisely reflect the 
relative abundance of different ADAR2 mRNA isoforms.  
Consistent with previous reports (Slavov and Gardiner, 2002), mRNA isoforms 
containing exon 4 represented a small percentage of total ADAR2 transcripts in 
the brain of wild-type mice (Fig 15C). Our data also demonstrated that exon 4 is 
rarely used in all the non-neuronal tissues tested. In addition, the use of the 
proximal A-I splice site roughly paralleled the tissue-specific editing at the -1 site 
in wild-type animals (Figure 14). In RNA isolated from various tissues of ΔECS 
mice however, ADAR2 mRNA isoforms containing the 47 nucleotide cassette 
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Figure 15 Ablation of ADAR2 alternative splicing in ECS mice. 
A. A schematic diagram of four possible ADAR2 mRNA isoforms 
resulting from alternative splicing of exon 4 and inclusion or 
exclusion of 47-nucleotide cassette (-47 and +47) at the 5'-boundary 
of exon 5 are indicated. 
B. Standard curve for fluorescent RT-PCR analysis. Plasmids 
encoding ADAR2 isoforms that contained (+47) or lacked (-47) the 
47-nucleotide cassette were mixed at different ratios and amplified 
by PCR using a fluoroscein-labeled sense and a non-labeled 
antisense primer. Amplicons corresponding to alternatively spliced 
ADAR2 variants were resolved by 2.5% agarose gel electrophoresis, 
and quantified by phosphorimager analysis. A correlation between 
the experimentally observed ratio of ADAR2 isoforms and the ratio 
predicted by the plasmid mixture is indicated with the best-fit line 
2
determined by linear regression (R  = 0.9764).
C. Quantitative analysis of ADAR2 alternative splicing. The positions 
of RT-PCR amplicons corresponding to the four alternatively spliced 
ADAR2 transcripts described in Fig.15A are indicated. The 
percentage of total ADAR2 transcripts containing the 47-nucleotide 
cassette but not exon 4 (3/5 +47) is shown (mean ± SEM; n=3).
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were not observed (Figure 15C), demonstrating that deletion of the ECS region 
concomitantly ablated ADAR2 autoediting and the ability to use the proximal 
splice site in intron 4 to include an additional 47 nucleotides in the ADAR2 coding 
region in vivo. The single exception to this observation was the presence of a 
PCR amplicon from testis RNA that migrated at the same position as the 3/5+47 
isoform, representing less than 2% of the ADAR2 mRNA transcripts. Due to the 
low abundance of this amplicon, we were unable to identify and further 
characterize this molecule.  
 
ADAR2 protein expression in the ΔECS mice 
The ablation of ADAR2 autoediting and proximal splice acceptor use in ΔECS 
mice resulted in the predominant production of the 3/5 -47 mRNA isoform that 
encodes the full-length, functional ADAR2 protein. By contrast, the 3/5 +47 
isoform is the predominant isoform of ADAR2 mRNA in most tissues from wild-
type animals, encoding a putative truncated, inactive ADAR2 protein resulting 
from the premature translation termination in the altered reading frame. We 
therefore anticipated that the ablation of ADAR2 autoediting would lead to 
elevated ADAR2 protein expression in ΔECS mice in comparison to the wild-type 
animals.  
Homogenates were prepared from multiple tissues of wild-type and ΔECS mice 
and ADAR2 protein levels were assessed by quantitative Western blotting 
analysis using antisera directed against ADAR2 and a constitutively expressed 
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house-keeping protein, β-actin, which served as a endogenous loading control. 
We first performed the quantitative Western blotting analysis on a series of 
sample dilutions to identify the linear range of detection for both ADAR2 and β-
actin. 20ug was determined to be the optimal amount for this analysis as it was in 
the middle of the linear range of detection. As shown in figure 16, in the lung, 
where the greatest level of ADAR2 autoediting and 47 nt inclusion was observed 
in wild-type animals (Figure 14, 15), the greatest increase (3.7 fold) in ADAR2 
protein expression was identified in ΔECS mice. Similarly, in the brain and heart, 
where the +47 isoform represented >50% of the total ADAR2 mRNA (Figure 14, 
15), a 2.4- and 1.7-fold increase in ADAR2 protein was revealed, respectively. In 
tissues such as the liver and testis, where ADAR2 autoediting and proximal 
splice site use occurred at a low frequency in wild-type mice (Figure 14, 15), 
ablation of this RNA modification did not affect the ADAR2 protein expression 
significantly (Figure 16A). 
In the simplest model, where ADAR2 autoediting represents the rate-limiting 
step for determining alternative splice-site selection, the equation Y=100/(100-X) 
can define the relationship between the extent of tissue-specific proximal splice 
site use in wild-type tissues (X) and the expected increase in ADAR2 protein 
expression (Y) in the ΔECS mice. While plotting the observed increase of ADAR2 
protein expression in ΔECS mice (Figure 16A) against the percentage of 47 
nucleotide cassette containing mRNA isoform in wild-type tissues (Figure 15C), 
we obtained a curve roughly paralleled with the predicted curve (Figure 16B). 
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Figure 16 Quantitative Western blotting analysis of ADAR2 protein 
levels in tissues isolated from wild-type and ECS mice. 
A. A representative Western blot using 20μg of total protein from each 
tissue is presented; the expected migration positions for ADAR2 and -
actin are indicated. The fold increase of ADAR2 protein expression in 
ECS versus wild-type tissues was quantified after normalization to the 
internal -actin control (mean±SEM; n=5; **, p<0.01; *, p<0.05).
B Correlation between ADAR2 autoediting levels in isolated tissues 
from wild-type mice (from Fig. 14) and the relative increase in ADAR2 
protein expression from the corresponding tissues in ECS animals 
was determined by non-linear regression with the equation Y = A/(B-X) 
(A=70; B=98, r2=0.92). The best fit line defined by the observed 
[Y=70/(98-X)] and predicted [Y=100/(100-X)] data are indicated with 
solid and dashed lines, respectively.
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These results confirmed that ADAR2 autoediting is a key regulator for modulating 
the expression of ADAR2 protein in vivo. 
 
Characterization of ADAR2 mRNA expression in ΔECS mice 
To confirm that the elevated ADAR2 protein levels in ΔECS mice can be 
attributed to the alterations in 3’-splice site selection, rather than an increase in 
the steady state levels of ADAR2 transcripts, a ribonuclease protection assay 
was developed to quantify isoform-specific ADAR2 mRNA expression in tissues 
of wild-type and ΔECS mice. Due to the complexity of alternative splicing events 
between exon 3 and 5 to generate four mRNA isoforms, the ribonuclease 
protection probe was designed to generate a 481 nt fragment from the 3/5 -47 
mRNA isoform, whereas a partial protection by all other mRNA isoforms and the 
unspliced ADAR2 pre-mRNA gave rise to a 332nt protected specie (Figure 17A). 
We were unable to develop a probe that specifically recognizes the mRNA 
isoform containing the 47 nucleotide cassette due to the presence of multiple 
editing sites at positions 10, 23 and 24 relative to the -1 site (Dawson et al., 
2004). Results from this assay demonstrated significant increases in the 3/5 -47 
ADAR2 mRNA isoform expression in the brain and lungs of ΔECS mice. 
Consistent with the lower levels of autoediting observed in wild-type animals 
(Figure 14), no significant increase in the 3/5 -47 isoform was seen in RNAs 
isolated from the liver and the testis in ΔECS mice (Figure 17).  
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Figure 17 Characterization of ADAR2 mRNA isoform expression. 
A. A schematic diagram indicating the structures and sizes of predicted 
RNase protection products resulting from ADAR2 pre-mRNAs or 
ADAR2 mRNA isoforms containing or lacking the 47-nucleotide 
cassette or exon 4. 
B. Ribonuclease protection analysis of total RNA (10 g) from tissues 
of wild-type and ECS mice; the predicted migration positions for 
protected RNA fragments are indicated. The fold increase in ADAR2 
RNA isoforms lacking both the 47-nucleotide cassette and exon 4 (3/5 
-47) in ECS versus wild-type tissues was quantified after 
normalization to the internal cyclophilin control (mean ± SEM; n=6 for 
brain, lung and heart; n=3 for liver and testis). 
C. Quantification of relative ADAR2 mRNA expression between wild-
type (  ) and ECS (  ) using real-time RT-PCR analysis (mean ± SEM; 
n=6 for brain, lung and heart; n=3 for liver and testis).
87
BC
0.00
0.25
0.50
0.75
1.00
1.25
testisheart liverlungbrain
*
R
e
la
ti
v
e
 A
D
A
R
2
m
R
N
A
 e
x
p
re
s
s
io
n
A
332 nt
3 53/5 (+47)
3 4 53/4/5 (-47)
3 4 53/4/5 (+47)
2
2
2
2
3 5
481 nt
3/5 (-47)
unspliced 4
intron 4
5
481nt
brain lung heart liver testis
WT DECS WT DECS WT DECS WT DECS WT DECS
cyclophilin
1
.7
"
0
.1
**
1
.5
"
0
.1
**
1
.2
"
0
.1
1
.0
"
0
.3
0
.9
"
0
.1
3/5 (-47)
fold over WT):(
332nt
88
To further confirm that deletion of the ECS region did not result in alterations of 
the steady-state level of ADAR2 transcripts, a real-time RT-PCR-based strategy 
using a Taqman probe spanning exon 9 and 10 was performed to quantify total 
ADAR2 mRNAs in multiple tissues from wild-type and ΔECS mice. Results from 
this analysis revealed that despite the increase in ADAR2 protein expression in 
ΔECS animals, there was no significant change in the total level of ADAR2 
mRNAs in most tissues (Figure 17C). Interestingly, a 30% decrease in ADAR2 
mRNA was observed in whole mouse brain that may have resulted from a tissue-
specific instability of the modified ADAR2 pre-mRNA or a compensatory 
alteration to counteract elevated ADAR2 protein levels.   
 
Selective increase in RNA editing by ADAR2 overexpression 
ADAR2 has been shown to be responsible for the site-selective editing of 
numerous mammalian RNAs (Bhalla et al., 2004; Burns et al., 1997; Niswender 
et al., 1999; Rueter et al., 1999; Wang et al., 2000). To examine whether the 
observed increase in ADAR2 protein expression in ΔECS mice resulted in 
changes for ADAR2 substrates editing, we quantified the extent of editing for 
known ADAR2 targets, including the D- site of 5-HT2C R transcripts, the R/G site 
of the GluR-2 pre-mRNA and the I/V site of the Kv1.1 mRNA (Bhalla et al., 2004; 
Hartner et al., 2004; Hoopengardner et al., 2003; Wang et al., 2000; Wang et al., 
2004). Since the expression of most identified ADAR2 substrates is restricted to 
the nervous system (Higuchi et al., 2000), we first determined the editing 
efficiency of these ADAR2 targets in RNA isolated from whole brain of wild-type 
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and ΔECS mice using a modified primer-extension analysis (Burns et al., 1997). 
While the level of editing at the D-site for 5-HT2C R transcripts (47.8%) isolated 
from wild-type mice is comparable to previous studies (Burns et al., 1997; Wang 
et al., 2004), a  15% increase in editing was seen for ΔECS animals. Similarly, 
editing at the R/G site and I/V sites of GluR-2 and Kv1.1 transcripts were 
increased by 11% and 10%, respectively, in ΔECS mice (Table 4).  
To determine whether the changes in editing were limited to ADAR2-selective 
sites, we also examined the editing efficiencies of two well-characterized ADAR1 
sites, the +60 site in the GluR-2 pre-mRNA and the A-site in 5-HT2CR transcripts 
(Burns et al., 1997; Hartner et al., 2004; Higuchi et al., 2000; Wang et al., 2000). 
The extent of editing at the A-site in 5-HT2CR transcripts isolated from whole 
mouse brain decreased from 74% in wild-type animals to 64% in ΔECS mice; 
however, editing at the +60 site was not significantly changed. Since ADAR1 
mRNA expression in the brains of ΔECS mice was not different from wild-type 
animals as determined by real-time RT-PCR analysis (Figure 18), it is unlikely 
that the decrease in the A-site editing in 5-HT2CR transcripts of ΔECS mice 
results from decrease in ADAR1 expression. As suggested by previous studies, a 
competition between ADAR1 and ADAR2 for binding to the 5-HT2CR RNA 
substrate (Chen et al., 2000; Hartner et al., 2004) could explain how elevated 
ADAR2 protein expression in the ΔECS brains could lead to decrease in ADAR1-
selective modification of the A-site. 
In addition to the ADAR2 pre-mRNA transcript, the only other known ADAR2 
substrates expressed in non-neuronal tissues is the RNA encoding the Kv1.1 
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editing site tissue  wild-type DECS
Site-specific RNA editing of ADAR substrates
transcript
% editing
5-HT R
2C brain 47.8"2.5 63.0"4.7**D
brainGluR-2 68.6"1.8 79.8"0.9**R/G
brainK 1.1V 37.0"3.1 46.7"2.6*I/V
testisK 1.1V I/V
liverK 1.1V I/V
heartK 1.1V I/V
lungK 1.1V ND
ND
ND
ND
ND
ND
ND
ND
I/V
5-HT R
2C brain
brainGluR-2
74.3"1.2
61.8"1.3 60.2"1.7
64.4"0.7***A
+60 site
Table 4 Site-specific RNA editing of ADAR substrates
The extent of editing for ADAR substrates from wild-type and ECS 
mouse tissues was determined by primer-extension analysis (see 
Material and Methods). Shaded are ADAR1 specific sites. Values for 
editing sites in brain-derived RNAs were obtained from 6 animals of 
each genotype, whereas values for RNAs isolated from other tissues 
were obtained from 3 animals of each genotype (mean ± SEM).
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Figure 18 ADAR1 mRNA expression in wild-type and ECS 
mouse brain. 
The relative level of ADAR1 mRNA expression in whole mouse 
brain from wild-type and ECS mice was quantified by real-time 
PCR (mean ± SEM; n=6).
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channel subunit. As ADAR2 transcripts can no longer be edited due to genetic 
modification in ΔECS mice, the I/V site in Kv 1.1 transcripts represents the only 
site that can provide further information about alternation in endogenous ADAR2 
activity in non-neuronal tissues due to ablation of ADAR2 autoediting. The region 
containing I/V site was amplified from total RNA of multiple wild-type and ΔECS 
peripheral tissues. Since Kv1.1 transcripts are encoded by an intronless gene, 
KCNA1, an RT-PCR reaction with no reverse transcriptase was included with 
every sample to confirm the absence of genomic DNA contamination.  
Surprisingly, no detectable levels of editing at the I/V site were observed in KV 1.1 
transcripts from lung, heart, liver and testis of either wild-type or ΔECS mice, 
suggesting A-to-I conversion to regulation KV1.1 channel function occurs 
exclusively in the brain. 
 
Phenotypic analysis of ΔECS mice 
Recent study from our laboratory have demonstrated that mice expressing a rat 
ADAR2 transgene, under the control of cytomegalovirus (CMV) promoter, 
developed adult onset obesity (unpublished data from Dr. Minati Singh), yet the 
ΔECS mice which have elevated ADAR2 expression have no obese phenotype 
(Figure 19). While ΔECS mice have increased ADAR2 protein expression in the 
lung, brain and heart, the CMV-driven rADAR2 transgene is highly expressed in 
skeletal muscle and demonstrated only marginal overexpression (1.2-fold) in the 
brain. The growth differences between the rADAR2 transgenic mice and ΔECS 
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Figure 19 Body-weight analysis of wild-type and ECS animals.
Body-weight of wild-type mice and ECS mice were taken once a 
week for 35 weeks (mean ± SD; n=6), statistic significance was 
determined by two-way ANOVA analysis, and no significance was 
detected.
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mice could result from the differential expression profile of ADAR2 protein in 
these distinctive mouse models. The exact mechanism and the target tissue for 
the obesity in rADAR2 transgenic mice are still under investigation. 
Despite significant alterations in the editing of ADAR substrates in ΔECS mice 
(Table 4) however, no overt phenotypic alterations were observed in mutant mice 
from birth through adulthood. Since any expected changes in ΔECS mice are de-
pendent upon the repertoire of ADAR targets affected by changes in ADAR2 
expression, and the majority of characterized editing events are limited to 
neurotransmitter receptors in the CNS, we assessed alterations in animal 
behavior using a gross examination based upon the neurological screen 
developed by Irwin (Irwin, 1968). This standardized method provides a 
behavioral and functional profile of wild-type and mutant mice by observational 
assessment of potential defects in gait or posture, motor control and coordination, 
changes in excitability and aggression, salivation, lacrimation, piloerection, 
defecation, and muscle tone. Results from this neurological screen identified no 
significant alterations in ΔECS mice from wild-type animals.  
 
ADAR2 autoediting during brain development. 
Previous studies using in situ hybridization have demonstrated that ADAR2 
expression in the brain is developmentally regulated (Paupard et al., 2000), with 
the expression of ADAR2 mRNA was first detected at embryonic day 19 (E19) 
and reaching maximal levels by postnatal day 21 (P21). To further examine the 
expression of ADAR2 mRNA in the brain during development, Michelle Jacobs in 
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our laboratory took the advantage of a Taqman-based real-time RT-PCR 
analysis. As shown in Figure 20, ADAR2 mRNA expression was detected as 
early as E15 and increased till P21, after which no further changes in ADAR2 
mRNA were observed (Figure 20A, personal communication from Michelle 
Jacobs). To examine ADAR2 autoediting during brain development, the RT-PCR 
analyses (described in figure 15) were performed on brain RNA harvested from 
different developmental stages. Results from this analysis demonstrated little 47 
nucleotide inclusion at E15, yet use of the proximal 3’- splice site increased with 
developmental increases in total ADAR2 mature mRNA expression (Figure 20B), 
suggesting that the modulation of ADAR2 expression by autoediting is 
developmentally regulated. To further assess ADAR2 autoediting during 
development, brain ADAR2 protein expression in wild-type and ΔECS mice at the 
age of P0 was compared, and no significant difference between the two 
genotypes was observed (Figure 20C), suggesting that ADAR2 autoediting may 
be not be important for regulating ADAR2 protein expression during the 
embryonic and neonatal development. 
 
Discussion 
Characterized by the presence of both dsRBDs and a catalytic adenosine 
deaminase domain, members of the ADAR family convert adenosine into inosine 
within double-stranded region of RNA, thereby modulating the genetic 
information passed through mRNA transcripts. A-to-I editing events have been 
shown to alter the coding sequences of mRNAs encoding AMPA and kainate 
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Figure 20 Developmental regulation of ADAR2 expression and 
autoediting in the brain of wild-type and ECS mice.
A. ADAR2 mRNA expressions in the brain at different developmental 
stages were quantified by real-time RT-PCR and normalized (as 
described in the Material and method) with the expression in the adult 
brain set up as 1. (courtesy from Michelle Jacobs, Vanderbilt 
University)
B. Quantitative analysis of ADAR2 alternative splicing during brain 
development. The percentage of total ADAR2 transcripts containing 
the 47-nt cassette but not exon 4 (3/5 +47) is quantified in total RNA 
isolated from the brains at different developmental stages, using the 
fluorescent RT-PCR analysis as described in the Material and method 
(mean±SEM; n=3).
C. Quantitative Western blotting analysis of ADAR2 protein levels in 
wild-type and ECS mice at the age of P0. The fold increase of ADAR2 
protein expression in ECS versus wild-type tissues was quantified 
after normalization to the internal -actin control (mean±SEM; n=5; **, 
p<0.01; *, p<0.05).
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ionotropic glutamate receptor subunits, the 5-HT2C receptor and the Kv1.1 
potassium channel subunit, resulting in the production of multiple protein 
isoforms with profoundly altered functional properties (Burns et al., 1997; 
Seeburg and Hartner, 2003). ADARs have the potential to affect more than the 
coding potentials of mRNA transcripts. In C. elegans, ADARs have been linked to 
the RNAi pathway (Tonkin and Bass, 2003). RNAs hyperedited by ADARs are 
selectively retained in the nuclei of mammalian cells, indicating that ADAR 
activity may serve to control the stability and nuclear export of transcripts (Kumar 
and Carmichael, 1997; Prasanth et al., 2005). Moreover, the discovery of 
numerous A-to-I editing events in the UTRs of human, mouse and C. elegans 
mRNAs further suggests a role for ADARs in regulating mRNA stability or 
translation efficiency (Morse et al., 2002; Morse and Bass, 1999).  
The exact mechanism by which site-specific adenosine modification is 
achieved in a naturally occurring substrate is still unknown. It has been shown 
that ADARs edit adenosines within any RNA duplex of sufficient length 
regardless of sequence; consequently, ADAR site-selectivity is predominantly 
determined by bulges and loops that separate base-paired sequence within 
imperfect RNA duplexes (Lehmann and Bass, 1999). However, when expressed 
at high levels, ADARs can edit adenosines in duplexes as short as 15 bp in 
length, so unregulated ADAR activity could lead to aberrant and deleterious 
mRNA sequence alterations (Herbert and Rich, 2001). In vitro experiments have 
suggested that ADAR overexpression may actually result in the inhibition of other 
dsRNA-binding proteins by competitively binding to their substrates (Chen et al., 
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2000). Two lines of transgenic mice generated in our laboratory, in which the 
CMV promoter drives the constitutive expression of either the wild-type or a 
catalytically inactive rADAR2 protein are severely obese due to hyperphagia, 
demonstrating a detrimental physiological consequence of unregulated ADAR 
expression that may result from aberrant dsRNA binding and competition with 
other dsRNA-binding proteins (Unpublished data from Dr. Singh).  
Just as excess ADAR activity can be harmful, lack of ADAR activity also has 
deleterious consequences. Genetically modified mice lacking ADARs die during 
either embryonic development (ADAR1) or shortly after birth (ADAR2), 
demonstrating the critical physiological importance of A-to-I RNA editing (Hartner 
et al., 2004; Higuchi et al., 2000; Seeburg and Hartner, 2003; Wang et al., 2000). 
While the GluR-2 Q/R site in wild-type mice is edited to nearly 100%, mice 
harboring a single non-editable GluR-2 allele developed seizures and die by 
three weeks of age (Brusa et al., 1995). In addition, clinical studies have 
associated alterations in ADAR editing with a number of CNS disorders including 
depression, schizophrenia, seizure susceptibility and amyotrophic lateral scler-
osis (Gurevich et al., 2002; Iwamoto and Kato, 2003; Kawahara et al., 2004; 
Kwak and Kawahara, 2005; Niswender et al., 2001; Sodhi et al., 2001; Vissel et 
al., 2001). All of these studies demonstrate that an optimal level of A-to-I editing 
is required for normal CNS function. Using computer-based algorithms, newly 
identified ADAR targets in the coding and non-coding regions of human and 
mouse transcriptsomes have increased the number of known A-to-I modification 
events by at least an order of magnitude (Athanasiadis et al., 2004; Blow et al., 
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2004; Clutterbuck et al., 2005; Kim et al., 2004; Levanon et al., 2004; Levanon et 
al., 2005; Morse et al., 2002). Identification of these new ADAR targets strongly 
suggests that ADARs may play important roles in a broader range of biological 
process than previously speculated and underscores the need for an organism to 
tightly regulate ADAR activity. 
Several lines of evidence have provided evidence for diverse cellular 
mechanism to modulate ADAR2 activity. ADAR2 is preferentially concentrated in 
the nucleolus, but can shuttle readily from the nucleolus to the nucleoplasm in 
response to increased expression of ADAR2 targets (Desterro et al., 2003). 
Translocation from the nucleolus to the nucleoplasm results in increased editing 
for ADAR2 substrates, suggesting that ADAR2 activity can be functionally 
regulated by subnuclear sequestration (Desterro et al., 2003; Sansam et al., 
2003). In addition, two alternative splicing events also have been demonstrated 
to affect ADAR2 activity in the cell. One such splicing event, in the region encod-
ing the deaminase domain, increases the enzymatic activity of ADAR2 by two-
fold (Gerber et al., 1997); whereas the other splicing event is dependent upon the 
ability of ADAR2 to edit its own pre-mRNA, thereby promoting the insertion of a 
47-nucleotide cassette near the 5’-end of the open reading frame to abort 
translation prematurely (Rueter et al., 1999). To determine whether ADAR2 
autoediting and subsequent alternative splicing represent important regulatory 
mechanisms for modulating ADAR2 protein expression and activity, our 
laboratory has generated mutant mice in which the ability of ADAR2 to edit its 
own transcript has been selectively ablated.  
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To eliminate the ability of ADAR2 to generate a proximal 3’-splice site 
preceding exon 5, we disrupted the predicted RNA duplex required for A-to-I 
conversion using Cre-mediated recombination to remove the evolutionarily 
conserved ECS region in intron 4 (Dawson et al., 2004; Rueter et al., 1999; 
Slavov and Gardiner, 2002). In the current study, deletion of the ECS region in 
mice efficiently eliminated editing at the -1 site (Figure 14) and inclusion of the 
47-nucleotide cassette in mature ADAR2 transcripts (Figure 15), indicating that 
the ECS element is essential for the -1 site editing and subsequent alternative 
splicing in vivo. Ablation of -1 site editing promoted the use of the distal 3’-splice 
site immediately preceding exon 5 (Figure 14), to allow exclusion of the 47-
nucleotide cassette and increase the relative expression of the ADAR2 mRNA 
isoform (3/5 -47) that encodes the full-length, functional protein (Figure 17). 
Accordingly, increased ADAR2 protein expression in multiple tissues (Figure 16) 
and a concomitant increase in the editing of ADAR2 substrates were observed in 
ΔECS mice (Table 4), strongly supporting the hypothesis that ADAR2 autoediting 
serves as a negative feedback mechanism for modulating ADAR2 protein 
expression. 
The possibility that the increased ADAR2 expression in ΔECS mice resulted 
from alterations in the steady-state level of ADAR2 transcripts, via changes in 
RNA stability or transcription, were ruled out by real-time PCR analysis; no 
change in the level of ADAR2-derived RNAs was observed in most tissues, with 
the exception of the brain, where the level of mature ADAR2 mRNA was 
decreased by 30% when compared to control animals (Figure 17C). Decreased 
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levels of GluR-2 mRNA have been reported previously in mice with a deletion of 
the ECS element required for GluR-2 editing (Q/R site), due to nuclear accumu-
lation of incompletely processed primary GluR-2 transcripts (Brusa et al., 1995). 
A similar decrease in GluR-2 mRNA expression was also observed in ADAR2-
null mice, where a low level of GluR-2 editing (Q/R site) was observed (Higuchi 
et al., 2000), indicating that RNA editing may be a prerequisite for efficient 
splicing and processing of GluR-2 pre-mRNAs (Higuchi et al., 2000). Ribonucle-
ase protection analysis of ADAR2 RNA isoforms from wild-type mouse brain 
indicated that the transcripts encoding the full-length functional protein (3/5 -47) 
represented 26% of the total ADAR2 transcript population, which include both 
mature and unprocessed ADAR2 mRNA (Figure 17B). Since quantitative RT-
PCR analysis further indicated that the same ADAR2 mRNA isoform (3/5 -47) 
comprised 26% of the total mature mRNA, these data would suggest that unpro-
cessed precursors in wild-type animals represents only a small percentage of the 
total ADAR2-derived RNAs. By contrast, analysis of ΔECS mice revealed no 
detectable RNA isoforms with the 47-nucleotide cassette and only 2.5% of the 
transcripts containing exon 4 (Figure 15), indicating that the 332 nt protected 
species observed from RNase protection analysis of ΔECS mice (Figure 17; 22% 
of total ADAR2 RNAs) almost exclusively represented ADAR2 pre-mRNA. These 
data indicated that the ablation of ADAR2 autoediting results in an accumulation 
of unprocessed RNA precursors, as with mutant mice in which GluR-2 (Q/R site) 
editing was eliminated. The hypothesized inefficient RNA processing due to lack 
of A-to-I editing could explain the decreased level of mature ADAR2 transcripts in 
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RNA isolated from ΔECS mouse brain (Figure 17). Further experiments directly 
quantify the relative level of ADAR2 pre-mRNA will provide more information 
about how RNA editing at the -1 site affects on ADAR2 transcript maturation.  
Consistent with the increased expression of ADAR2 protein, editing efficiencies 
at ADAR2 specific sites are elevated in the brain of ΔECS mice. In addition, a 
decrease in ADAR1-mediated editing was also observed at the A-site of the 5-
HT2C receptor transcripts, which is the only known substrate containing both 
ADAR1- and ADAR2-specific sites within close proximity (13 nt). Previous 
studies had shown that editing at the D- site, a specific ADAR2 site, was elevated 
in mice lacking ADAR1 expression, and in vitro experiments also demonstrated 
that increased expression of ADAR1 or ADAR2 can decrease the editing 
efficiency of the D- or A-sites on 5-HT2C receptor RNA duplex, respectively, 
suggesting a competition between ADAR1 and ADAR2 on 5-HT2C R transcripts 
(Chen et al., 2000; Hartner et al., 2004). Our in vivo data is consistent with this 
hypothesis as the ΔECS mice showed decreased editing of the ADAR1-selective 
A-site on 5-HT2C R transcripts. Interestingly, no alteration was detected for the 
editing at the +60 site of the GluR-2 transcripts, even though a specific ADAR2 
site (Q/R site) is located within the same predicted RNA duplex. The +60 and the 
Q/R sites in GluR-2 pre-mRNA are 60 nt apart compared with the A- and D-sites 
in the 5-HT2CR transcript which are within 13 nt of one another (Figure 4). Since 
previous studies have demonstrated that the minimal length of an RNA duplex for 
ADAR binding is 15-20 bp (Nishikura et al., 1991), we reasoned that while 
ADAR1 and ADAR2 can bind independently on the GluR-2 duplex without 
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interfering with each other, whereas their binding sites overlap on in the 5-HT2C 
receptor pre-mRNA.  
Despite significant alterations in the editing of ADAR substrates in ΔECS mice 
(Table 4), no overt phenotypic alterations were observed in mutant mice from 
birth through adulthood. Since all altered editing events are limited to the CNS 
(Table 4), we assessed alterations in animal behavior using a gross examination 
based upon the neurological screen developed by Irwin (Irwin, 1968). In addition, 
body weight analysis was performed on the wild-type and ΔECS mice from the 
age of 4 to 35 weeks and revealed no differences between the two genotypes. 
However, it is too early to draw any conclusion about how ablation of ADAR2 
autoregulation affects mouse physiology. For mouse growth rate studies, animals 
were maintained on breeder’s chow, a relatively high fat diet which could 
promote growth in mice and mask any differences between wild-type and mutant 
animals. Repeating these studies with an altered diet could provide give us a 
more conclusive answer on whether ΔECS mice have deficits in growth 
compared to wild-type animals.  
Comparisons of ADAR2 genes between multiple vertebrate species (rat, 
mouse, chicken, zebrafish, pufferfish and humans) have revealed >90% intronic 
sequence conservation in the predicted region of the inverted repeats, with a 
majority of the nucleotide differences clustered in predicted bulge regions within 
the duplex (Dawson et al., 2004; Rueter et al., 1999; Slavov and Gardiner, 2002) 
(Figure 11). Furthermore, alternative 3’-splice site selection has also been shown 
to be conserved among these species (Slavov and Gardiner, 2002), suggesting 
105
that ADAR2 autoediting and alternative splicing represent an important biological 
process to modulate ADAR2 protein expression in vertebrates. Recent studies of 
the Drosophila ADAR gene (dADAR) have demonstrated that the dADAR 
enzyme is capable of editing its own mRNA to generate a protein isoform with a 
serine-to-glycine substitution close to the dADAR active site (Keegan et al., 
2005). This single amino acid alteration appears to restrict dADAR function, since 
the glycine-containing isoform encoded by the edited dADAR mRNA is less 
active than the genomically-encoded protein product. Ubiquitous or muscle-
specific expression of a dADAR transcript that cannot be modified by A-to-I 
conversion results in increased editing of a voltage-gated calcium channel 
transcript (Ca alpha 1D) and subsequent lethality (Keegan et al., 2005), demon-
strating that the ability of dADAR to edit its own mRNA is critical for Drosophila 
viability. In an example of what appears to be convergent evolution, dADAR and 
ADAR2 have developed completely different autoediting strategies to modulate 
ADAR activity. The difference in phenotypic consequences between these 
species could result from the fact that the transgenic dADAR2 expression in 
drosophila could be much higher than mouse ADAR2 expression in ΔECS mice. 
In addition, despite multiple unbiased approaches undertaken to identify more 
ADAR substrates in vertebrates, only two novel nonsynomous A-to-I conversions 
were discovered in transcripts encoding proteins that are putatively important in 
the CNS (Levanon et al., 2005). However, many more transcripts encoding 
proteins involved in rapid neurotransmission have been found to undergo A-to-I 
editing in drosophila (Hoopengardner et al., 2003), suggesting that the role of 
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ADAR in drosophila CNS may be more critical than that in vertebrates. 
Alternatively, compensatory alterations in vertebrates could serve to circumvent 
the adverse phenotypic consequences that may result from increases in ADAR2 
expression and alterations in editing patterns for ΔECS mice. 
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CHAPTER III 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions  
A-to-I RNA editing is the most widespread RNA editing modification identified 
in metazoa. Mice lacking ADAR1 expression die during embryonic development 
and ADAR2-null mice died from postnatal seizure, demonstrating the critical 
physiological significance of ADAR function (Hartner et al., 2004; Higuchi et al., 
2000; Seeburg and Hartner, 2003). In mammals, ADAR-mediated RNA editing 
has been shown to alter the coding potentials of transcripts encoding proteins 
that are important to normal CNS functions, including 5-HT2C receptor, iGluRs 
and Kv1.1. In Drosophila, most known ADAR substrates are transcripts encoding 
channels, receptors and synaptic proteins that are involved in fast 
electrochemical transmission (Hoopengardner et al., 2003). Moreover, A-to-I 
RNA editing has also been shown to alter the splicing pattern of pre-mRNAs 
encoding a non-receptor protein tyrosine phosphatase and ADAR2 (Beghini et al., 
2000; Rueter et al., 1999). In addition to affecting RNA coding potential and 
splicing pattern, ADARs also have been linked to the RNAi pathway in C. 
elegans (Tonkin and Bass, 2003). Systematic screening for novel A-to-I 
conversion using either computational algorithms or a massive sequencing 
approach revealed numerous novel A-to-I editing sites in human, mice and 
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chicken transcriptsome (Blow et al., 2004; Levanon et al., 2004; Levanon et al., 
2005). The majority of these newly-identified A-to-I conversions are predicted to 
occur within the non-coding region of RNA transcripts. Interestingly, previous 
studies have demonstrated that edited RNA may be selectively retained in the 
nuclei in mammalian cells and subsequently degraded by inosine-specific 
ribonuclease (Kumar and Carmichael, 1997; Scadden and O'Connell, 2005; 
Scadden and Smith, 2001). More recently, the 3’UTR of cationic amino acid 
transporter 2 (CAT2) transcribed nuclear RNA (CTN-RNA) was found to be 
subjected to ADAR editing and play an important role in nuclear retentions of the 
transcript (Prasanth et al., 2005), suggesting the A-to-I conversions in the UTRs 
of transcripts may be involved in controlling the RNA stability and nuclear 
transport. 
The ability of ADARs to produce alterations in the coding potentials of RNA 
transcripts, introduce alternative splicing patterns or modulate RNA stability could 
be deleterious to the organism if it were non-specific or unregulated. Therefore a 
number of mechanisms have been evolved to tightly regulate ADAR activity. 
Numerous studies have demonstrated that ADAR1 expression and activity are 
regulated at the transcriptional, post-transcriptional as well as post-translational 
levels. The transcription of ADAR1 is controlled by one of the two alternative 
promoters, Pi and Pc, which drive the production of transcripts encoding an IFN-
inducible 150kD protein that can shuttle between the nucleus and cytoplasm, or a 
constitutive 110kD nuclear protein respectively (George and Samuel, 1999; 
Patterson and Samuel, 1995; Patterson et al., 1995; Thomis et al., 1992). The 
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IFN-inducible transcripts undergo alternative splicing modifications, which 
generates multiple mRNA isoforms encoding proteins that possess comparable 
catalytic activity but differ in the spacer regions between dsRBDs and deaminase 
domains (Liu et al., 1997). Two post-translational mechanisms have been 
identified to regulate ADAR1 activity. Firstly, it has been demonstrated that 
ADAR1 is highly concentrated in the nucleolus of mammalian cells and the 
expression of an editing-competent ADAR substrate can relocate the 
endogenous ADAR1 from the nucleolus to nucleoplasm where the substrate 
transcripts accumulate, suggesting that the nucleolus can serve as a storage 
spot for ADAR1, while the editing reaction takes place in the nucleoplasm 
(Desterro et al., 2003). Interestingly, recent studies have also  demonstrated that 
the ADAR1 is modified by SUMO-1 in the nucleolus, and sumoylation decreases 
ADAR1 editing activity (Pinto Desterro et al., 2005). Therefore, it is possible that 
these two mechanisms may act synergistically to restrain ADAR1 activity in the 
nucleolus and regulate the availability of ADAR1 protein at sit of action in vivo. 
In comparison to studies on ADAR1, limited information exists regarding the 
regulation of ADAR2 expression and activity. Similar to ADAR1, ADAR2 activity 
appears to be modulated by nucleolar sequestration (Desterro et al., 2003; 
Sansam et al., 2003); however, since ADAR2 protein doesn’t have the motif 
required for SUMO-1 mediated modification, it is unlikely that ADAR2 activity is 
affected by sumoylation (Pinto Desterro et al., 2005). In addition to subnuclear 
localization, ADAR2 expression and activity are also regulated by alternative 
splicing. One such splicing event results in the insertion of 30 (human) or 10 
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(mouse, rat) amino acids in the deaminase domain of ADAR2 and leads to the 
production of protein with increased activity. However, it is not clear if this 
alternative splicing is regulated by any cellular or molecular cues. The other 
alternative splicing event in the 5’-end of the coding region has been identified as 
a subsequent event of ADAR2 editing on its own pre-mRNA. This alternative 
splicing results in the insertion of a 47nt cassette in the open reading frame, 
causing a frame shift and eventually resulting in premature translation 
termination (Rueter et al., 1999). In the current studies, we have demonstrated 
that the ADAR2 autoediting and subsequent alternative splicing represent a 
negative-feedback regulatory mechanism by which ADAR2 expression and 
activity are modulated in vivo. In the ΔECS mice, where ADAR2 autoediting has 
been selectively ablated, ADAR2 protein expression increases in multiple tissues, 
and ADAR2-selective RNA editing is also elevated in the brain. The observed 
increases in ADAR2 protein expression correlate with the extent of ADAR2 
autoediting observed in wild-type tissues, indicating that ADAR2 autoediting is a 
key regulator of ADAR2 protein expression and activity in vivo. 
It is commonly believed that the process of negative feedback provides a 
noise-reduction mechanism for biological systems and can serve to minimize the 
effects of fluctuations caused by cellular disturbance (Becskei and Serrano, 2000; 
Kaern et al., 2005; Paulsson, 2004; Simpson et al., 2003). The ability of ADAR2 
to edit its own pre-mRNA not only provides a mechanism to limit ADAR2 protein 
expression, but also serves as a strategy by which A-to-I RNA editing activity 
may be modulated in response to changes in the expression of ADAR substrates 
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or other RNA binding proteins. It has been demonstrated that different substrates 
can compete with one another for ADAR binding and activity (Dawson et al., 
2004). In a situation where ADAR substrates expression is increased, editing at 
the -1 site in ADAR2 pre-mRNA would be inhibited, resulting in the increased 
production of full-length, functional ADAR2 protein. In this aspect, the ADAR2 
autoediting could serve as a sensor to monitor the expression of numerous 
ADAR substrates in the nucleus, thereby modulating ADAR2 activity to maintain 
steady-state levels of A-to-I conversion (Figure 21). 
 
Future directions 
Genetically modified mice lacking ADAR2 autoregulation (ΔECS mice) provide 
an excellent model for studying the self-regulatory mechanisms modulating 
ADAR2 expression and activity in vivo. Further molecular analysis and behavioral 
characterization of these mutant animals will provide further insight regarding the 
regulation of A-to-I RNA editing in different tissues for distinct ADAR substrates 
and the physiological significance of ADAR2 autoregulation. 
 
Editing efficiency of recently identified substrates 
Four codon-altering A-to-I RNA editing events were recently identified in genes 
encoding FLNA, BLCAP, CYFIP2 and IGFBP7 (Clutterbuck et al., 2005; Levanon 
et al., 2005). Unlike previously identified ADAR substrates in mammals, none of 
these RNAs encodes a receptor protein. Among the four substrates, FLNA and 
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Figure 21 Model of ADAR2 autoregulation. 
A schematic diagram of the biosynthetic processes involved in the 
production of ADAR2 is presented, showing a region of the ADAR2 
pre-mRNA between exon 3 and 5, the predicted RNA duplex 
required for A-to-I editing, and the position of the -1 site (*). The RNA 
processing pathway lacking -1 site editing, leading to the production 
of full-length (711aa) ADAR2 is indicated with dashed arrows; the 
functional domains in ADAR2 (NLS, nuclear localization signal; 
dsRBD, double-stranded RNA binding domains and adenosine 
deaminase domain) are indicated. The biosynthetic pathway 
involving A-to-I conversion at the -1 site (*), leading to the 
production of a predicted 9 kD (83aa) protein, is indicated with solid 
arrows; the hatched box represents the amino acid sequences 
encoded by an altered reading frame resulting from proximal 3'-
splice acceptor use and inclusion of an additional 47nt in the mature 
ADAR2 transcript.
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CYFIP2 are strongly expressed in the CNS and transcripts isolated from mouse 
brain contain both edited and non-edited RNA isoforms (Levanon et al., 2005). 
FLNA has been shown to cross-links actin into orthogonal networks in the cortical 
cytoplasm (Hartwig and Stossel, 1975) and participates in the anchoring of 
membrane proteins (van der Flier and Sonnenberg, 2001). A-to-I modification in 
FLNA transcripts result in a Q/R substitution within the 22nd immunoglobulin-like 
domain, which has been previously shown to be important for binding to the small 
GTPase Rac1 (Ohta et al., 1999), and interact with the Drosophila homologue of 
CYFIP2 (Schenck et al., 2003). BLCAP encodes a 10kD globular protein 
containing two highly hydrophobic regions, a proline-rich area that resembles the 
src homology 3 domain binding site and a SPXX motif which is usually found in 
transcription factors (Gromova et al., 2002). Differential expression of BLCAP 
mRNA has been found in bladder cancer and renal cancer cell lines (Gromova et 
al., 2002; Rae et al., 2000). Multiple editing sites have been predicted in the 5’-
UTR and the N-terminal region of the protein and verified only in RNA isolated 
from the brain. The three editing sites in the coding region all represent non-
synonymous amino acid alterations (Q/R, Y/C and K/R) and are well conserved 
from C. elegans to human, suggesting a biological relevance for RNA editing in 
regulating the function of this gene (Clutterbuck et al., 2005). As we have shown 
that extent of editing is altered in the brains of ΔECS mice for multiple ADAR 
substrates, it will be worthwhile to not only compare the editing of FLNA, CYFIP2 
and BLCAP RNAs isolated from the brain of wild-type and ΔECS mice, but also 
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subsequent studies to determine the effects of such A-to-I modifications on the 
function of the encoded protein products.  
The RNA editing event in IGFBP-7 transcripts is of particular interest since this 
RNA modification takes place in the lung (Levanon et al., 2005), since ΔECS 
mice show the greatest increase of ADAR2 protein expression in the lung, 
quantification of IGFBP-7 RNA editing will give some insight on whether ADAR2 
is responsible for this RNA modification and serve as a preface to determine how 
ADAR2 autoediting can affect IGFBP-7 activity and lung function. 
 
Regulation of A-to-I RNA editing in peripheral tissues 
The absence of the I/V site editing of Kv1.1 RNAs in peripheral tissues, despite 
the presence of ADAR2 protein, suggests that there may be other regulatory 
mechanisms to modulate A-to-I RNA editing in tissues other than the brain. The 
coexpression of ADAR3 and Kv1.1 in some areas of the brain suggests that 
ADAR3 may serve as a modulator in ADAR2-mediated Kv1.1RNA editing (I/V site) 
in the brain. However, we can not rule out the possibility that a peripheral tissue-
specific inhibitory factor could suppress I/V editing or that the expression of 
ADAR2 protein in peripheral tissues does not reach a threshold for efficient Kv1.1 
editing. Recent studies have demonstrated that RNA editing in BLCAP 
transcripts is also brain specific, despite the ubiquitous expression of this gene  
(Clutterbuck et al., 2005), indicating that further investigation is needed to 
address the possible mechanisms regulating ADAR2 editing in peripheral tissues. 
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 Functional consequence of altered Kv1.1 RNA editing in ΔECS mice 
The substitution of isoleucine residue with a valine moiety fasten the Kv1 
potassium channel re-sensitization process by 20 fold in a heterologous 
expression system, suggesting that I/V site editing in transcripts encoding the α 
subunit of this channel is important in regulating the homomeric Kv1 channels 
kinetics (Bhalla et al., 2004). In ΔECS mice, editing at the I/V site of Kv1.1 
transcripts was elevated by 10%, presumably leading to a faster recovery from 
inactivation in comparison to the Kv1 channels in the wild-type animals. The 
function of Kv1 voltage-gated potassium channel has been implicated in learning 
process and amphetamine-elicited neurobehavioral effects (Kourrich et al., 2005; 
Pirisino et al., 2005). Mice lacking the Kvβ1.1 subunit have a reduced K+ current 
inactivation in hippocampal CA1 pyramidal neurons and demonstrate impaired 
learning ability in both water maze test and social transmission of food 
preference task (Giese et al., 1998). Since faster recovery from inactivation, 
resulting from I/V site editing, could lead to a similar reduced K+ current 
inactivation to that observed in the Kvβ1.1-deficient mice, ΔECS mice may have 
similar learning defects due to increased editing in the α subunit of Kv1 channel. 
Therefore, electrophysiological characterizations on CA1 pyramidal cells in the 
hippocampal slices and behavior analyses on the learning behavior for wild-type 
and ΔECS mice should be performed to provide further information regarding the 
physiological and behavioral consequences of altered Kv1.1 RNA editing due to 
ADAR2 overexpression. 
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 Potential compensatory mechanisms to ADAR2 autoregulation deficiency 
Studies described in this thesis have demonstrated that although ΔECS mice 
reveal obvious changes in ADAR2 expression and activity, no behavioral 
alteration has been identified. ADAR2 autoediting is conserved from pufferfish to 
human (Slavov and Gardiner, 2002), suggesting an evolutionary significance of 
this RNA modification in a wide array of species. It is possible that the absence of 
behavioral alterations in ΔECS mice results from activation of compensatory 
mechanisms to counteract the adverse consequence due to overexpression of 
ADAR2.  As demonstrated in Figure 20, ADAR2 autoediting is developmentally 
regulated and the relative abundance of mRNA isoforms containing the 47nt 
cassette gradually increases from 15% (E15) to 75% (adult). Since ADAR2 
autoediting is a key regulator of ADAR2 protein expression, and the increase in 
ADAR2 protein in ΔECS mice can be predicted by extends of 47nt inclusion in 
the wild-type counterparts (Figure 16), it is likely that ADAR2 protein expression 
will increase gradually elevated during postnatal development in ΔECS mice. 
Therefore, compensatory mechanisms may be activated and adapt to the 
ADAR2 protein overexpression during postnatal development in ΔECS animals.  
To prevent the development of possible adaptive compensation during 
postnatal development, we can take advantage of the cre-loxP system for the 
inducible ablation of ADAR2 autoediting using Cre recombinase under the control 
of an inducible promoter containing Tetracycline- or estrogen-response elements. 
Mice carrying the lox-ECS-lox allele (Figure 13) can be mated with inducible cre 
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transgenic mice to generate offspring (lox-ECS-lox/iCre) in which the ECS region 
can be removed in a temporally-inducible fashion. Cre recombinase expression 
can be activated in adult lox-ECS-lox/iCre mice, and molecular/behavioral 
analysis can be performed on mice with/without Cre recombinase expression to 
reveal the molecular and physiological consequence resulting from sudden 
ablation of ADAR2 autoediting.   
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APPENDIX 
 
Irwin screen examination 
 
I. Physical factors and gross appearance 
a. Coat color 
A=albino 
Ag=Agouti 
Bl=Black 
b. Presence of whiskers 
0=none 
1=a few 
2=most, but not a full set 
3=a full set 
c. Appearance of fur 
0=un-groomed and disheveled 
1=somewhat disheveled 
2=well-groomed 
d. Piloerection 
0=none 
1=most hairs standing on end 
e. Patches of missing fur on face 
0=none 
1=some 
2=extensive 
f. Patches of missing fur on body 
0=none 
1=some 
2=extensive 
g. wounds 
0=none 
1=signs of previous wounding 
2=slight wounds present 
3=moderate wounds present 
4=extensive wounds present  
 
II. Observation of behavior in a novel environment 
a. Transfer behavior 
0=coma 
1=prolonged freeze (>10sec.), then slight movement 
2=extended freeze, then moderate movement 
3=brief freeze (a few seconds), then active movement 
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4=momentary freeze, then swift movement 
5=no freeze, immediate movement 
6=extremely excited (“manic”) 
b. Body position 
0=completely flat  
1=lying on side 
2=lying on back 
3=sitting or standing 
4=rearing on hind legs 
5=repeated vertical leaping 
c. Spontaneous activity 
0=none, resting 
1=casual scratch, groom, slow movement 
2=vigorous scratch, groom, meoderate movement 
3=vigorous rapid/dart movement 
4=extremely vigorous, rapid/dart movement 
d. Respiration rate 
0=gasping, irregular 
1=slow, shallow 
2=normal 
3=hyperventilation 
e. Tremor 
0=none 
1=mild 
2=marked 
f. Palpebral closure 
0=Eyes wide open 
1=E yes ½ closed 
2=Eyes closed 
g. Piloerection 
0=none 
1=coat stood on end 
h. Gait 
0=normal 
1=fluid but abnormal 
2=limited movement only 
3=incapacity 
i. Pelvic elevation 
0=markedly flattened 
1=barely touches 
2=normal (3mm elevation) 
3=elevated (more than 3mm elevation) 
j. Tail elevation 
0=dragging 
1=horizontally extended 
2=elevated 
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k. Urination 
0=none 
1=little 
2=moderate  
3=extensive 
 
III. Reflexes and reactions to simple stimuli 
a. Touch escape 
0=no response 
1=mild (escape response to firm stroke) 
2=moderate (rapid response to light stroke) 
3=vigorous (escape response to approach) 
b. Positional passivity 
0=struggles when restrained by tail 
1=struggles when restrained by neck (finger grip, no scruffed) 
2=struggles when held supine (on back) 
3=struggles when restrained by hind legs 
4=Does not struggle 
c. Trunk curl 
0=absent 
1=present 
d. Reaching reflex 
0=None 
1=Upon nose contact 
2=Upon vibrasse contact 
3=before vibrasse contact (18mm) 
4=Early vigorous extension (25mm) 
e. Body tone 
0=Flaccid, no return of cavity to normal 
1=Slight resistance 
2=Extreme resistance, board like 
f. Pinna reflex 
0=None 
1=Active retraction, moderately brisk flick 
2=hyperactive, repetitive flick 
g. Preyer reflex 
0=None 
1=Active retraction, moderately brisk flick 
2=Hyperactive, repetitive flick 
 
IV. Measures recorded during supine restraint 
a. Skin color 
0=Blancked 
1=Pink 
2=Bright, deep red flush 
b. Limb tone 
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0=Slow, bradycardia 
1=Normal 
2=Fast, tachycardia 
c. Abdominal tone 
0=No resistance 
1=Slight resistance 
2=Moderate resistance 
3=Marked resistance 
4=extreme resistance 
d. Righting reflex 
0=No impairment 
1-10=Number of seconds required to right 
e. Air righting reflex 
0=No impairment 
1-10=Number of seconds required to right 
 
V. Grip strength, motor coordination, and locomotor activity 
a. Grip strength 
0=None 
1=Slight grip, semi-effective 
2=Moderate grip, effective 
3=Active grip, effective 
4=Unusually effective 
b. Wire maneuver 
0=Active grip with hindlegs 
1=Difficulty to grasp with hindlegs 
2=Unable to grasp with hindlegs 
3=Unable to lift hindlegs, falls within seconds 
4=Falls immediately 
c. Wire hang 
0=Active grip with hindlegs 
1=Difficulty to grasp with hindlegs 
2=Unable to grasp with hindlegs 
3=Unable to lift hindlegs, falls within seconds 
4=Falls immediately 
d. Inverted screen 
0-60=Numbers of seconds before falling 
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